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The homeobox transcription factor SIX1 contributes to both tumor development 
and progression. Numerous studies have determined that the inappropriate expression of 
embryonic genes, in particular transcription factors, contributes to carcinogenesis. SIX1 
is essential for the development of numerous organs including the auditory and olfactory 
system as well as the kidney, by promoting proliferation, survival and migration of 
progenitor cells during embryogenesis. SIX1 has also been shown to increase cancer cell 
proliferation, survival and invasion. The aberrant expression of SIX1 occurs in numerous 
adult and pediatric cancers. We have previously determined that our in-vitro model 
system for HPV16-mediated tumorigenesis shares many important features with cervical 
cancer and enables us to study the molecular mechanisms of transformation and 
immortalization in our cell human keratinocyte (HKc) lines. SIX1 mRNA and protein 
levels are overexpressed in our HPV16-transformed HKc lines at the differentiation-
resistant stage (HKc/DR) compared with early passage, HPV16-immortalized HKc 
(HKc/HPV16) and in HKc/HPV16 compared to normal HKc. Furthermore, we have 
recently determined that SIX1 overexpression in HKc/HPV16 induces the differentiation-
resistant phenotype characteristic of HKc/DR, and that SIX1 overexpression in HKc/DR 
induces tumorigenicity. In this study, we explored the role of SIX1 as a regulator of 
growth and transformation in normal HKc, and its role in the maintenance of growth and 
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a transformed phenotype in HKc/HPV16 and HKc/DR. We determined that loss of SIX1 
is not tolerated by HKc/DR, which appear to be “addicted” to this oncogene. Decreased
SIX1 expression results in slower proliferation and decreased HPV16 E6/E7 mRNA 
levels. We utilized Affymetrix GeneChip Arrays to explore the gene expression changes 
associated with decreased SIX1 expression in HKc/DR. Ingenuity Pathway Analysis, 
real-time PCR and functional cell-based assays determined that SIX1 is vital for cell 
survival; the decline in SIX1 causes a transition from the mesenchymal phenotype 
characteristic of HKc/DR towards the standard epithelial phenotype (mesenchymal-
epithelial transition, MET). MET is accompanied by a switch in TGF-β signaling from an 
EMT-inducing tumor promoter to a tumor suppressor in HKc/DR cells. Additionally, we 
observed that SIX1 overexpression in normal HKc extends their lifespan and induces 
epithelial-mesenchymal transition, EMT. In summary, our studies suggest that SIX1 is 
necessary for cell survival in HPV-16 –transformed cells and may potentially become a 
suitable therapeutic target for HPV-driven cancers.
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1.1 SIX1 IN NORMAL AND HPV-16 TRANSFORMED HUMAN KERATINOCYTES 
The retinal determination gene network (RDGN) was first discovered in 
Drosophilia eye formation and, over the years, has become a model system for analyzing 
the genetic and molecular mechanisms of cell fate determination. RDGN is composed of 
dachshund (dac/ Dach), tyrosine phosphatase eyes absent (eya/ Eya) and the SIX family 
sine oculis (so/ SIX) (Liu et. al., 2016). Genes from this network are highly conserved 
during evolution and encode nuclear transcription factors and cofactors that regulate 
morphogenesis in mammals. This network is aberrantly expressed in several pediatric and 
adult cancers: Eya and SIX genes are known to be upregulated and Dach genes are shown 
to be downregulated (Liu et. al., 2016). 
SIX1 belongs to the SIX superfamily of homeobox genes, which encode 
transcription factors. These proteins have an essential role in organogenesis and 
tumorigenesis through the activation and inhibition of numerous downstream targets. The 
SIX superfamily are homologous to Drosophilia sine oculis (so), optix and DSix4 family 
of genes. The SIX family members in flies have homologs in many organisms within the 
animal kingdom, including mammals. Analysis of the SIX gene set within vertebrates has 
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shown that each of the SIX1 gene has two members of each subclass: Six 1/2 (sine oculis, 
so), Six 3/6 (optix) and Six 4/5 (DSix4) (Kumar et. al., 2009).
 
The SIX family members are DNA-specific transcription factors that consist of 
two evolutionarily conserved domains.  DNA binding is elicited through the homeobox 
nucleic acid recognition domain (HD), which are 60 amino acids in length. The SIX 
domain (SD) is directly adjacent to HD, 146 amino acids in length and contributes to 
protein-protein interactions (Kumar et. al., 2009). SIX1 is ubiquitously expressed in 
humans and plays a critical role in the development of major organ systems including the 
muscle, kidney, brain, auditory and olfactory. SIX1 utilizes cofactors, coactivators and 
corepressors to regulate the transcription of downstream targets. In the absence of Eya, 
Dach regulates SIX1 to suppress gene expression. On the other hand, Eya phosphatase 
recruits coactivators to initiate transcription of target genes (Kumar et. al., 2009). 
Numerous studies have highlighted the importance of SIX1/EYA in development 
and disease, including cancer. For example, mutation of the SIX1 gene causes the human 
disease brancchio-oto-renal (BOR) syndrome. Classified as a developmental disorder, 
BOR syndrome is clinically characterized with hearing loss and malformations of the 
kidney and/-or urinary tract. Specifically, researchers have observed one SD mutation as 
well as two HD mutations that affect SIX1-EYA interaction and SIX1- DNA binding 
(Ruf et. al., 2004) Overall, targeting this transcriptional complex will benefit patients in 
the clinical setting.
 
SIX1 is a master regulator of development where it plays a role in normal 
organogenesis. Numerous studies have identified that the inappropriate expression of 
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embryonic genes in cancer, in particular transcription factors, contribute to 
carcinogenesis (Abate-Shen et. al., 2002). Elevated SIX1 levels in malignant cells is 
sufficient to increase cellular proliferation, survival and invasion, similar to what is 
observed during embryonic development (Christensen et. al., 2008). In breast cancer cell 
lines, gene amplification is a type of mechanism shown to increase SIX1 expression 
(Reichenberger et. al., 2005).
 
The aberrant expression of SIX1 occurs in numerous adult 
human cancers, including breast, ovarian, cervical and hepatocellular carcinomas, and 
pediatric malignancies including rhabdomyosarcoma and Wilms’ tumor (Coletta et. al., 
2010). 
  
SIX1 overexpression has been shown to correlate with increased malignancy, 
lymph node metastasis and poor survival in cancer patients (Coletta et. al., 2008; 
Micalizzi et. al., 2009). For example, studies have established that the overexpression of 
SIX1 in immortalized, non-tumorigenic mammary epithelial cells induces malignant 
transformation, leading to highly aggressive and invasive tumors in nude mice. Studies 
have demonstrated that SIX1 is overexpressed in half of primary mammary carcinomas 
and most metastatic lesions (Coletta et. al., 2008).
 
 Along the same lines, SIX1 
overexpression in human breast cancer cell lines induces epithelial-mesenchymal 
transition (EMT), enhancing metastasis in-vitro and in-vivo
 
(Coletta et. al., 2008; 
Micalizzi et. al., 2009).
 
SIX1 has also been shown to be overexpressed in cervical cancer 
cell lines and tissues, which are correlated with increased malignancy and metastasis 
(Tan et. al., 2011; Zheng et. al., 2010). SIX1-induced EMT is associated with Smad-
dependent transforming growth factor-beta (TGF-β) signaling and increased expression 
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of TGF-β receptor type I (TβRI), allowing SIX1 to induce lymphangiogenesis and 
metastasis by up-regulating VEGF-C, a lymphangiogenic factor (Wang et. al., 2012). 
 
1.2 EPITHELIAL-MESENCHYMAL TRANSITION (EMT) 
SIX1 overexpression is associated with tumor initiation, progression and 
metastasis. Whole genome sequencing of tumor tissues implicate SIX1 in its ability to 
decrease epithelial-related genes and increase mesenchymal-related genes and that SIX1-
induced tumors undergo EMT, primarily depending on the activation of TGF-β and p38-
MAPK (Xu H et. al., 2014; Xu H et. al., 2015). Through the interaction of SIX1 with 
Wnt and mitogen-activated protein kinase (MAPK)/ERK signaling, tumors are able to 
attain EMT and stem cell-like features (Xu H et. al., 2014).
 
Epithelial and mesenchymal cell phenotypes are established early in normal 
development. However, these two cell phenotypes are highly dynamic and constantly in 
motion, depending on the cell type and environment. The conversion between these cell 
phenotypes, mechanistically labelled as Epithelial-Mesenchymal Transition (EMT) and 
the reverse Mesenchymal-Epithelial Transition (MET), provides elasticity during 
embryogenesis, wound healing and regeneration of differentiated tissues (Micalizzi et. 
al., 2010). During developmental EMT, there are highly organized and well-defined 
multi-step events that allow the transition of immotile, polarized and cuboidal epithelial 
cells to gain a motile, apolar and fibroblastic phenotype. During carcinogenesis, epithelial 
cells undergoing EMT acquire resistance to suspension-induced cell death (anoikis) with 
the subsequent increase in cellular migration and invasion. This allows them to efficiently 
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respond to extracellular signals, involving extracellular matrix (ECM) components and 
soluble growth factors including transforming growth factor-beta (TGF-β) and epidermal 
growth factor (EGF) (Lee et. al., 2012; Micalizzi et. al., 2010). The reverse holds true for 
mesenchymal cells where they are able to begin MET (Figure 1.1) (Micalizzi et. al., 
2010). 
Cancer-associated EMT has been observed in several malignancies including 
breast, cervical and colon. EMT becomes exaggerated in malignant cells and is associated 
with the downregulation of epithelial markers, such as E-cadherin, and the upregulation 
of mesenchymal markers, such as N-cadherin and Vimentin- the major hallmarks in the 
EMT cascade (Lee et. al., 2012; Micalizzi et. al., 2010). The metastatic spread of 
malignant cells occurs in a multi-stepwise fashion, following EMT. Tumorigenic cells 
leave their primary site, invade the basement membrane, intravasate into the local 
lymphovascular, disseminate through the circulation, and extravasate into a secondary 
site, thereby colonizing distant organs, depending on the cancer type, setting the stage for 
metastasis (Figure 1.2) (Micalizzi et. al., 2010). Additionally, numerous regulators of 
EMT have been misexpressed in cancers such as TGF-β, Wnt, Snail/Slug, Twist and 
SIX1. Potentially, these and various other transcription factors appear to have a clinical 
significance and have been recently identified to be prospective novel drug targets (Lee 





Figure 1.1 Transition between epithelial and mesenchymal state of cells. 
 
 
Figure 1.2 The metastatic spread of malignant cells facilitated through EMT. 
Tumorigenic cells leave their primary site, invade the basement membrane, intravasate 
into the local lymphovascular, disseminate through the circulation, and extravasate into a 
secondary site, leading to metastasis. At the distant colonized organ, cells can revert to an 






1.3 TRANSFORMING GROWTH FACTOR-BETA (TGF-β) 
Similar to many developmental signaling pathways misused in cancer, TGF-β 
signaling is known to be connected to numerous pathologic processes and its function 
during organogenesis parallels its role in neoplasia (Micalizzi et. al., 2009). TGF-β is an 
ubiquitously expressed cytokine that contributes a dual role in tumor formation- 
suppressing tumor growth in normal cells and early neoplastic lesions, while promoting 
invasive migration and metastasis in the later stages of carcinogenesis (Micalizzi et. al., 
2009; Xu H et. al., 2014; Xu H et. al., 2015). This soluble growth factor is heavily 
involved in EMT and is a regulator of tumorigenesis. SIX1 has been shown to increase 
TGF-β signaling; this signaling pathway is a critical contributor to cancer progression 
and metastasis by inducing oncogenic EMT. SIX1 expression selectively promotes the 
pro-tumorigenic activity of TGF-β while halting its growth-inhibitory functions 
(Micalizzi et. al., 2009). TGF-β contains three isoforms: TGFβ1, TGFβ2 and TGFβ3; and 
mediates signaling by binding to three receptors: TGF-β receptor type I (TβRI), type II 
(TβRII) and type III (TβRIII) (Meulmeester et. al., 2011; Xu H et. al., 2014; Xu H et. al., 
2015). 
 
1.4 HUMAN PAPILLOMAVIRUS (HPV) AND CERVICAL CANCER 
 
Cervical cancer is the leading cause of cancer morbidity and second leading cause 
of cancer mortality in women worldwide. There are about 500,000 new cases and 
300,000 deaths annually due to cervical cancer (Peralta-Zaragoza et. al., 2012). Virtually 
all cervical cancer cases are due to persistent infection with a high-risk human papilloma 





Currently, 79 million people in the USA have acquired an HPV infection. By the 
age of 50, about 80% of women will have acquired an HPV infection (Society AC., 2013; 
Peralta-Zaragoza et. al., 2012; Saslow et. al., 2012).
 
HPVs are small, non-enveloped viruses containing circular, double-stranded 
DNA. HPV infects the epithelial cells of skin and mucosae. The HPV genome encodes 
six to eight early and two late proteins. There are approximately 200 HPV types, 40 of 
which can infect the genital mucosa (Faridi et. al., 2011). HPVs can be further classified 
based on whether or not they lead to cervical cancer or benign genital warts: hence, we 
distinguish high-risk (oncogenic) types- that cause virtually 99% of cervical cancer cases- 
from low-risk (non-oncogenic) types that cause anogenital warts. Among the oncogenic 
HPV types, HPV16 and 18 are the most common, causing about 70% of cervical cancers. 
The non-oncogenic HPV types include HPV6 and 11, responsible for about 95% of 
genital warts (Crow JM, 2012; Grainge et. al., 2005).
 
Most HPV infections are asymptomatic and spontaneously clear within 9-18 
months, or (in some cases) the HPV remains latent at undetectable levels in the cervical 
epithelium. However, approximately 10% of infected individuals cannot naturally clear a 
high-risk HPV infection and are at risk for developing cervical cancer, which is known to 
be a slow but progressive disease. Progression to cervical carcinogenesis first starts with 
an infection to the genital mucosae of a high-risk HPV type. As the infection persists due 
to a multitude of factors, this can progress through early and then late stages of dysplasia- 
Cervical Intraepithelial Neoplasia I, II and III (CIN I, CIN II, CIN III) before developing 
into invasive cervical carcinoma (Saslow et. al., 2012). Although new infections decrease 
with age, risk of persistence is known to increase with age. Currently, there are two main 
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methods known to prevent or detect persistent, high-risk HPV infection. Primary 
prevention with a prophylactic Gardasil-9 vaccine can prevent infections by nine HPV 
types: 6, 11, 16, 18, 31, 33, 45, 52 and 58 (Harper DM et. al., 2017). 
 
Secondary 
prevention with the Papanicolaou (Pap) smear test can detect abnormal cytology of 














Figure 1.3 High-risk HPV infection and progression to invasive cervical carcinoma. 
Cervical cells can clear an infection through the host immune system or potentially 
progress. Persistors can progress to CIN I, which can potentially regress or progress to 
CIN II/III. At the later stages of pre-malignancy, clinical regression is possible but 
progression is probable. The main methods to prevent and/or detect an HPV infection 
include a prophylactic Gardasil-9 vaccine or the Pap test. 
 
 
Vaccine Pap smear 
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1.5 IN-VITRO MODEL SYSTEM OF HPV16-MEDIATED TRANSFORMATION OF 
NORMAL HUMAN KERATINOCYTES (HKc) 
Our laboratory has developed an in-vitro model system of HPV16-mediated 
transformation of normal cells to explore the cellular and molecular events associated 
with HPV infection. Primary or secondary cultures of human foreskin keratinocytes go 
through a series of defined premalignant steps that represent the early and late stages of 
cervical carcinogenesis. Normal human keratinocytes (HKc) were isolated from neonatal 
foreskin tissue and transfected with pMHPV16d, which contains two copies of the 
HPV16 DNA in a head-to-tail configuration, and selected with G418. This resulted in 
immortalization of the transfected cells (HKc/HPV16), which represents the first 
transformed stage in the in-vitro model.  With continuous passaging of HKc/HPV16, 
HPV16 sequences are amplified and integration into host chromosomes take place 
(Pirisi et. al., 1987).  Similar to normal HKc, these immortalized cells were cultured in 
keratinocyte-serum free medium (KSFM), requiring both epidermal growth factor (EGF) 
and bovine pituitary extract (BPE) for proliferation.  In addition, normal HKc and 
HKc/HPV16 cells are sensitive to differentiation triggered by serum and high calcium 
levels.  Nonetheless, HKc/HPV16 cells can be cultured in the absence of EGF and BPE.  
This gives rise to growth factor independent HKc (HKc/GFI) cells.  An additional 
selection step was performed, where HKc/GFI were exposed to 5% fetal bovine serum 
(FBS) and 1mM calcium chloride (Figure 1.4). In this step, cells that do not differentiate 
in response to these two reagents are obtained and are consequently called differentiation 
resistant cells (HKc/DR) (Pirisi et. al., 1987, 1988).  This is the last stage of premalignant 
transformation in our model system and these cells are not tumorigenic when injected 
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into nude mice.  In order to undergo malignant conversion, HKc/DR need to be 
transfected with other transforming genes such as viral ras or herpes simplex virus type 2 
(HSV2) DNA (DiPaolo et. al., 1989; DiPaolo et. al., 1990). We have repeatedly shown 
that HKc/DR are completely resistant to the anti-proliferative effects of TGF-β, whereas 
HKc/HPV16 and normal HKc are sensitive to the tumor inhibiting effects of TGF-β 
(Creek et. al., 1995). 
We have established this in-vitro system in order to investigate various stages of 
malignant transformation. We utilized microarrays to identify genes whose altered 
expression may lead to transformation in this multi-step, pre-malignant process of in-
vitro progression. Among the gene expression profiles that we had identified and that 
needed to be further studied was SIX1 (Wan F et. al., 2008). This particular gene was 
shown to be altered during the early and later stages of our model system in comparison 
to normal cells. 
 




1.6 SUMMARY AND GOAL OF RESEARCH 
 SIX1 overexpression has been shown to increase cancer cell proliferation, 
survival and invasion. The overexpression of SIX1 is associated with tumorigenesis and 
metastasis with poorer overall survival (Christensen et. al., 2008).  We have previously 
determined that SIX1 mRNA and protein levels are overexpressed in our HPV16-
transformed HKc lines at the differentiation-resistant stage (HKc/DR) compared with 
early passage, HPV16-immortalized HKc (HKc/HPV16) and in HKc/HPV16 compared 
to normal HKc. Furthermore, we have recently determined that SIX1 overexpression in 
HKc/HPV16 induces the differentiation-resistant phenotype characteristic of HKc/DR, 
and that SIX1 overexpression in HKc/DR induces tumorigenicity. These findings 
strongly suggest that SIX1 has a role in regulating the growth and transformation of 
normal HKc, and that it plays an important role in the maintenance of growth and a 
transformed phenotype in HKc/HPV16 and HKc/DR. In summary, our studies suggest 
that SIX1 is necessary for cell survival in HPV-16 –transformed cells and may potentially 
become a suitable therapeutic target for HPV-driven cancers. 
 The main goal of this study is to explore the role of SIX1 in HPV16-transformed 
human keratinocytes by following the cellular and molecular changes associated with the 








INHIBITION OF SIX1 EXPRESSION PRODUCES MESENCHYMAL-
EPITHELIAL TRANSITION AND DECREASES E6/E7 EXPRESSION IN 
HPV16-TRANSFORMED HUMAN KERATINOCTYES 
 
2.1 INTRODUCTION 
Cervical cancer is the leading cause of cancer morbidity and second leading cause 
of cancer mortality in women worldwide. There are about 500,000 new cases and 
300,000 deaths annually due to cervical cancer. Virtually all cervical cancer cases are due 
to persistent infection with a high-risk human papilloma virus (HPV). Infection with 
HPV is the most common sexually transmitted viral disease (STD). 
 
Currently, 79 million 
people in the USA have an HPV infection. By the age of 50, about 80% of women will 
have acquired an HPV infection (American Cancer Society; Peralta-Zaragoza et. al., 
2012; Saslow et. al., 2012).
  
HPVs are small, non-enveloped viruses containing circular, double-stranded 
DNA. HPV infects the epithelial cells of skin and mucosae. The HPV genome encodes 
six to eight early and two late proteins. There are approximately 200 HPV types, 40 of 
which can infect the genital mucosa. HPVs can be further classified based on whether or 
not they lead to cervical cancer or benign genital warts: hence, we distinguish high-risk 
(oncogenic) types- that cause virtually 99% of cervical cancer cases- from low-risk (non-
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oncogenic) types that cause anogenital warts. Among the oncogenic HPV types, HPV16 
and 18 are the most common, causing about 70% of cervical cancers. The non-oncogenic 
HPV types include HPV6 and 11, responsible for about 95% of genital warts. Most HPV 
infections are asymptomatic and are spontaneously cleared within 9-18 months, or (in 
some cases) the HPV remains latent at undetectable levels in the cervical epithelium. 
However, approximately 10% of infected individuals cannot naturally clear a high-risk 
HPV infection and are at risk for developing cervical cancer. The Gardasil-9 vaccine can 
prevent infections by nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52 and 58 (Harper DM et. 
al., 2017). 
Numerous studies have determined that the inappropriate expression of 
embryonic genes in cancer, in particular transcription factors, contribute to 
carcinogenesis (Abate-Shen C et. al., 2002). Among the embryonic genes that also play a 
role in cancer development, the sine oculis homeobox homolog 1 (SIX1) is essential for 
the development of numerous organs including the auditory and olfactory system as well 
as the kidney by promoting proliferation, survival and migration of progenitor cells 
during embryogenesis. SIX1 has been shown to increase cancer cell proliferation, 
survival and invasion, similar to what is observed during embryonic development 
(Christensen et. al., 2008). In fact, many parallels exist between normal development and 
tumorigenesis. The aberrant expression of SIX1 occurs in numerous adult human cancers, 
including breast, ovarian, cervical and hepatocellular carcinomas as well as pediatric 




SIX1 overexpression has been shown to correlate with increased malignancy, 
lymph node metastasis and poor survival in patients afflicted with cancer (Coletta et. al., 
2008; Micalizzi et. al., 2009). For example, SIX1 is overexpressed in half of primary 
mammary carcinomas and most metastatic lesions (Coletta et. al., 2008). SIX1 has also 
been shown to be overexpressed in cervical cancer cell lines and tissues, which are 
correlated with increased malignancy and metastasis (Tan et. al., 2011; Zheng et. al., 
2010). Studies have established that the overexpression of SIX1 in immortalized and non-
tumorigenic mammary epithelial cells induces malignant transformation, leading to 
highly aggressive and invasive tumors in nude mice. Moreover, SIX1 overexpression in 
human breast cancer cell lines induces epithelial-mesenchymal transition (EMT), 
enhancing metastasis in-vitro and in-vivo (Coletta et. al., 2008; Micalizzi et. al., 2009).
 
 
Nonetheless, very few studies have elicited the effects of the loss of SIX1, especially in 
cervical carcinogenesis. Determining the role of SIX1 in the tumorigenesis and 
progression of cervical cancer could facilitate diagnosis and treatment. This work would 
contribute in our understanding of the deteriorative functions of SIX1 in cancers as a 
global regulator of malignant transformation. 
In order to study the cellular and molecular mechanisms of HPV-mediated 
transformation, Pirisi et. al. established an in-vitro model system to study keratinocytes 
progression toward the premalignant stages of cervical cancer. In brief, primary human 
keratinocytes (HKc) were immortalized by transfection with pMHPV16d, which contains 
a head-to-tail HPV16 DNA dimer, and selection with G418. These immortalized human 
keratinocytes (HKc/HPV16) were selected in growth factor (epidermal growth factor and 
bovine pituitary extract) free medium and became growth factor independent (HKc/GFI). 
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A differentiation-resistant (HKc/DR) phenotype was then obtained by selection in serum 
and calcium -supplemented medium.  HKc/DR cells are not tumorigenic but can form 
tumors in nude mice when these cells are transfected with activated Ras, Herpes Simplex 
Virus 2 (HSV2) or the SIX1 oncogene (DiPaolo et. al., 1989; DiPaolo et. al., 1990).
 
Microarray studies conducted in our laboratory indicated that the in-vitro model 
system reflects many cellular and molecular alterations characteristic of cervical cancer. 
Therefore, our system for HPV16-mediated multi-step carcinogenesis shares important 
features with cervical cancer and enables us to study the molecular mechanisms of 
transformation and immortalization in our cell lines. It has been shown that SIX1 mRNA 
and protein levels are overexpressed in all 4 cell lines (HKc/DR vs. HKc/HPV16), and 
SIX1 mRNA and protein levels are consistently up-regulated during progression from 
HKc/HPV16 to HKc/DR. SIX1 overexpression was also confirmed in about 25% of 
cervical cancer tissue samples in a tissue array. Microarray results identified the 
increased expression of SIX1 as a potential biomarker for cervical cancer (Wan F et. al., 
2008; Xu H et. al., 2014; Xu H et. al., 2015). 
HPV16 is the most common among the high-risk oncogenic papillomaviruses that 
contributes to cervical carcinogenesis (Zheng XH et. al., 2010; Zheng ZM et. al., 2011). 
HPV16-mediated transformation requires the continuous expression of the viral 
oncoproteins E6 and E7. These two oncogenes are necessary for malignant conversion 
where E6 binds to and promotes the degradation of the p53 tumor suppressor protein; and 
E7 binds to the Rb tumor suppressor protein thereby releasing the E2F transcription 
factor. Consequently, this leads to tumor initiation, proliferation and genomic instability 




SIX1 overexpression in HKc/DR is associated to the increasing expression of 
HPV16 E7 that marks premalignant progression of these cells. SIX1 is known to be 
primarily under the control of E2F (Young AP et. al., 2003). When E7 binds to 
unphosphorylated Rb, this tumor suppressor protein becomes inactivated and releases 
E2F. The displacement of E2F from Rb allows E2F to activate the cell cycle and 
promotes the aberrant expression of the embryonic gene SIX1 (Young AP et. al., 2003).
 
We have determined that SIX1 overexpression in early-stage HPV16-
immortalized human keratinocytes (HKc/HPV16) induces a differentiation-resistant 
phenotype, and that SIX1 overexpression in differentiation-resistant HPV16-transformed 
human keratinocytes (HKc/DR) induces tumorigenicity (Xu H et. al., 2014; Xu H et. al., 
2015). Furthermore, we have also shown that SIX1 modulates TGF-beta signaling by 
decreasing canonical (Smad-mediated) responses and increasing non-canonical TGF-beta 
signaling pathways in both HKc/HPV16 and HKc/DR (Xu H et. al., 2014; Xu H et. al., 
2015). We have also demonstrated that TGF-beta signaling through the Smads decreases 
E6 and E7 expression, and that in turn, E7 decreases cells’ sensitivity to growth inhibition 
by TGF-beta (Baldwin et. al., 2004). Therefore, it is reasonable to expect that a decrease 
in SIX1 levels may be accompanied by a decrease in E6 and E7 expression, which would 
in turn be reflected in the increase of p53 and Rb levels. 
With this knowledge in mind, we studied the role of SIX1 as a regulator of growth 
and transformation in HPV16-transformed human keratinocytes. Specifically, we studied 
the functional consequences of suppressing SIX1 at late stages of HPV16-mediated 
transformation of human keratinocytes by a variety of approaches. We could only obtain 
partial (up to 80%) and transient knockdown of SIX1, as treatment with different anti-
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SIX1 sh- or siRNAs resulted in widespread cell death. The knockdown of SIX1 resulted 
in slower proliferation rates and was associated with, decreased E6 and E7 mRNA and 
increased p53 and Rb protein levels. We conclude that SIX1 expression is vital for cell 
survival, particularly in our HKc/DR cell lines. The results of these studies will give us 
valuable insight into the complex pathways affected through SIX1 and the functional 
significance of its inappropriate expression and activity in cancers, particularly those due 
to HPV. 
 
2.2 MATERIALS AND METHODS 
Cell culture and treatment 
The cell lines discussed in this work, HKc/HPV16-d1, HKc/DRd-1 and 
HKc/DRd-2, have been described previously (Pirisi et. al., 1987, 1988) In short, normal 
HKc are isolated from neonatal foreskins and maintained in keratinocyte serum-free 
medium supplemented with epidermal growth factor (EGF) and bovine pituitary extract 
(BPE) (KSFM, Invitrogen, Carlsbad, CA). This medium will be referred as complete 
medium. Normal HKc were transfected with a recombinant plasmid containing two 
copies of the HPV16 DNA in a head to tail configuration. This gave rise to HPV16-
immortalized human keratinocytes, which are also cultured in KSFM. The immortalized 
cells were then selected in medium devoid of EGF and BPE, giving rise to Growth Factor 
Independent HKc (HKc/GFI). These cells were then further selected in basal KSFM 
supplemented with 5% fetal bovine serum (FBS) and 1 mM calcium chloride to give rise 
to differentiation resistant cell lines (HKc/DR). This medium will be referred as 
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differentiation-resistant (DR) medium. HKc/DR were transfected with SIX1, giving rise 
to HKc/DR-SIX1. These cells were also maintained in DR medium. All cells were 
maintained in a humidified atmosphere of 5% CO2 at 37° C. 
Plasmid constructs and stable transfection 
Independently-derived HKc/DRd-1 and HKc/DRd-2 cell lines at 70% confluency 
were transfected with a pSuper vector containing either a specific shRNA against human 
SIX1, HuSH-29 shRNA based vector (Oligoengine, Seattle, WA) or a scrambled shRNA. 
Additional plasmids utilized in this work include a pLXSN.neo vector expressing the 
HPV16- E7 viral oncogene and the Harvey rat sarcoma virus (Hras)-V12 oncogene in the 
pBABE.puro vector (Addgene, Cambridge, MA). Up to 5ug of the pLXSN.neo- E7 and 
pBABe.puro- Hras-V12 vector were used for transfection. Moreover, three different 
shRNA constructs against E7- that target three different positions within the HPV16 –E7 
mRNA sequence, cloned in the backbone of the pSUPER.retro plasmid were used. 4ug or 
5ug of anti-SIX1 shRNA construct and anti- E7 plasmid were used.  Transfection 
efficiency was monitored with the co-transfection of the pSUPER/puro plasmid (3:1 
w/v), expressing GFP. As a vector control, the pSUPER/puro plasmid was used. Cells 
were transfected with Lipofectamine 3000 (Invitrogen) following the manufacturer’s 
instructions. Stable transfectants were selected with 3 ug/ml Puromycin (Toku-E, 
Bellingham, WA). 
RNA interference (RNAi) 
HKc and HKc/DRd-1 cells were seeded in 6-well plates, grown to 70% 
confluency and transfected with anti-SIX1 or anti-E7 siRNA or anti-GFP siRNA 
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(control) duplexes using Lipofectamine RNAiMAX (Invitrogen) following the 
manufacturer’s instructions. The following sequences were utilized in this study for 
transfection with siRNAs targeting SIX1 and E7. SIX1-siR1: Forward 5’-
CCAGCUCAGAAGAGGAAUU, Reverse 5’-AAUUCCUCUUCUGAGCUGG;     
SIX1-siR2: Forward 5’-CACGCCAGGAGCUCAAACU,              
Reverse 5’-AGUUUGAGCUCCUGGCGUG; E7- siR1 (position 141):            
Forward 5’-GGACAGAGCCCAUUACAAU, Reverse 5’-
AUUGUAAUGGGCUCUGUCC; E7- siR2 (position 653): Forward 5’- 
GCUCAGAGGAGGAGGAUGA, Reverse 5’-UCAUCCUCCUCCUCUGAGC.            
90 pmol siRNA was used per well and cells were incubated for 24, 48 and 72 hours 
before being harvested for RNA and protein extraction, for real-time PCR and Enzyme-
linked immunosorbent assay analysis (ELISA), respectively. 
Retroviral Infection 
PA317 cells were transfected with four different shRNA constructs (Origene, 
Rockville, MD) against SIX1 that target four different positions within the human SIX1 
mRNA sequence. A pSuper vector containing a scrambled shRNA was used as a control. 
Stable transfectants were selected with 3 ug/ml puromycin. After approximately 24 
hours, virus-producing PA317 were cultured until sub confluent, fed fresh complete 
medium and the medium was collected after 24 h and filter-sterilized (0.22 u pore size). 
 Virus stocks were aliquoted and stored at -80 °C. High passage HKc/Drd-1 cells 
at 70% confluency were infected with control virus stock or anti-SIX1 shRNA virus in 
KSFM containing polybrene (6 ug/ml). HKc/DRd-1 cells were maintained in DR medium 
containing polybrene during the duration of the infection, approximately 24 hours. After 
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removal of virus-containing medium, the infected cells were re-plated and selected with  
3 ug/ml puromycin. 
Real-time PCR 
Total RNA was isolated from cells using the RNeasy Plus Micro Kit (Qiagen, 
Hilden, Germany). Reverse transcription was carried out with 1 μg of total RNA using 
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Real-time PCR was performed 
using iQ SYBR Green Supermix (Bio-Rad). All procedures followed the manufacturer’s 
instructions. The sequences of the primers used for real-time PCR are listed in Table 2.1. 
GAPDH was used as an internal control. All samples were assayed in duplicates. 
 
Table 2.1 Primer sequences used in Real-time PCR. Primer sequence 5’-3’. 
Genes Forward Reverse 
human β-catenin/ 
CTNNβ1 
TTG AAA ATC CAG CGT GGA 
CA 
TCG AGT CAT TGC ATA CTG TC 
human CTGF TTA CCA ATG ACA ACG CCT 
CCT 




TGC TCT TGC TGT TTC TTC GG TGC CCC ATT CGT TCA AGT AG 
human EGFR GGC CTA AGA TCC CGT CCA 
TC 
GTA AGA GGC TCC ACA AGC 
TCC 
human ETS1 GAT AGT TGT GAT CGC CTC 
ACC 




ACC AAC CTA CGG ATG ACT 
CG 
GCT CAT CAT CTG GCC ATT TT 
human GAPDH GGG AAG GTG AAG GTC GGA 
GTC AA 
TCT CAG CCT TGA CGG TGC 
CAT 
human GUSB CTGTCAAGGGCAGTAACCTGT AGATAGGCAGGGCGTTCGT 
human keratin 14 TGA GCC GCA TTC TGA ACG 
AG 
GAT GAC TGC GAT CCA GAG 
GA 
human keratin 15 AATGTGGAGATGGACGCAG TGGATCATTTCTGTGTTGGAGG 
human keratin 19 CTT CCG AAC CAA GTT TGA 
GAC 
AGC GTA CTG ATT TCC TCC TC 
 
22 
human ki-67 ACG CCT GGT TAC TAT CAA 
AAG G 





AAA ATT ACA CGC CAG ATT 
TGC C 
 
GGT GTG ACA TTA CTC CAG 
AGT TG 
human MMP9 AGT CCA CCC TTG TGC TCT 
TCC C 




ACA GTG GCC ACC TAC AAA 
GG 
CCG AGA TGG GGT TGA TAA TG 
human Occludin ATG ACA AGC GGT TTT ATC 
CA 
CTC CAG CTC ATC ACA GGA CT 
human p53 CGTGTGGAGTATTTGGATGAC AGTCTTCCAGTGTGATGATGG 
human PPARγ GCC CTT TGG TGA CTT TAT 
GGA 
GCA GCA GGT TGT CTT GGA TG 
human PTGS2 GCC CAG CAC TTC ACG CAT 
CAG 
AGA CCA GGC ACC AGA CCA 
AAG ACC 
human Rb CAA ACT TGG AGT TCG CTT 
GT 
TTC AGA ATC CAT GGG AAA GA 
human SIX1 ATT CTC ACC TCC CCA AAG TC ACT TAG GAC CCC AAG TCC AC 
human SNAIL ACC CCA CAT CCT TCT CAC TG TAC AAA AAC CCA CGC AGA 
CA 
human TβRI CTT AAT TCC TCG AGA TAG 
GC 
GTG AGA TGC AGA CGA AGC 
human TβRII GGT TCC TGT GTG CCC TTA TT TGC AAC CCA TGA AGG TAA 
AA 
human TWIST GTC CGC AGT CTT ACG AGG 
AG 
GCT TGA GGG TCT GAA TCT 
TGC T 
human Vimentin GAG AAC TTT GCC GTT GAA 
GC 
TCC AGC AGC TTC CTG TAG GT 
HPV16- E6 CAC AGT TAT GCA CAG AGC 
TGC 
CAT ATA TTC ATG CAA TGT 
AGG TGT A 
HPV16- E7 CCG GAC AGA GCC CAT TAC 
AAT 
ACG TGT GTG CTT TGT ACG 
CAC 
 
Enzyme-linked immunosorbent assay (ELISA) 
Protein was isolated from cells using the Cell Lysis Buffer from the PathScan 
Total p53 Sandwich ELISA kit (Cell Signaling, Danvers, MA). SigmaFAST Protease 
Inhibitor (Sigma, Saint Louis, MO) was added to the resulting supernatant. PathScan 
Total Rb Sandwich ELISA kit was then utilized according to the manufacturer’s 
instructions. 50 ug of protein/sample was loaded into the p53 pre-coated wells. 150 ug of 
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protein/sample was loaded into the Rb pre-coated wells. All samples were assayed in 
replicates of two or three. Absorbance was read at 450 nm within 30 minutes using a 
microplate reader. 
Cell proliferation assay 
To compare the growth rates of either HKc/DRd-1- SIX1sh or HKc/Drd-2-
SIX1sh and HKc/DRd-1-SCRAMsh or HKc/DRd-2-SCRAMsh, and HKc/HPV16d-1 the 
WST-8 dye reagent from the Cell Counting Kit-8 (CCK8) sensitive colorimetric assay 
was utilized (Dojindo, Rockville, MD). Proliferation was determined at 24-hour intervals. 
5,000 cells were plated per well in 24-well plates in their respective media (1ml/well). 
Cells were plated in triplicate wells and at the appropriate times, 50 ul of WST-8 dye 
solution was added to each well and the plates were placed in a CO2 incubator for            
2 hours. Absorbance was read at 450 nm with a microplate reader. 
Gene-expression microarray analysis and validation by SYBR green real-time PCR 
Total RNA from HKc/DR-SIX1-siRNA1, HKc/DR-SIX1-siRNA2 and HKc/DR-
control-siRNA was isolated using Qiagen’s RNeasy Plus Micro Kit according to the 
manufacturer’s protocol. RNA quality was assessed using an Agilent 2100 Bioanalyzer 
and RNA Integrity Numbers ranged from 9.5 to 10.0. Microarray experiments were 
performed using the Affymetrix GeneChip Human Gene 2.0 ST Arrays as we have 






Results were expressed as the mean ± standard deviation (SD). Data were 
interpreted using student’s t-test. P ≤ 0.05, P ≤ 0.01 or P ≤ 0.001 were considered 
statistically significant and indicated in the figures by *, ** or ***, respectively. 
 
2.3 RESULTS 
2.3.1 THE KNOCKDOWN OF SIX1 AFFECTS CELL VIABILITY IN HKc/DR 
We utilized shRNA constructs targeting the human SIX1 gene to explore the 
effects of suppressing this oncogene in HPV16-transformed human keratinocytes. Anti-
SIX1-shRNA-encoding sequences and a control, scrambled shRNA were cloned in the 
pSuper-retro plasmid backbone (Oligoengine) and the resulting plasmids transfected into 
two HKc/DR cell lines, HKc/DRd-1 and HKc/DRd-2 (Pirisi et. al., 1987).
 
Transfected 
cells were briefly selected with puromycin until vector controls died (approx. 72 h). Cells 
were then collected for RNA extraction and plated for a growth curve (Figure 2.1, A). 
The shRNA decreased SIX1 mRNA levels to about 20% of control (maximum) (Figure 
2.1, B) and cells transfected with the anti-SIX1 shRNA exhibited much slower growth 
than their controls, although after 96h in culture, recovery could already be observed in 
one of the transfected lines (Figure 2.1, A). Further cultivation of these cells resulted in 
SIX1 mRNA levels returning to 100% of control and proliferation rates recovering 
completely (data not shown). Upon visual inspection, phase contrast photographs taken 
of cells co-transfected with pSuper-retro-scrambled or pSuper-retro-SIX1-shRNA and 
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GFP, at various times after transfection, demonstrated that loss of SIX1 leads to cell 









Figure 2.1 Loss of SIX1 in HKc/DR affects proliferation and HPV16- E6/E7 mRNA 
expression levels. (A) The rate of proliferation decreases in HKc/DRd-1 and HKc/DRd-2 
transfected with SIX1-shRNA plasmid. Cell proliferation at 24-hour intervals was 
determined utilizing the WST-8 dye reagent from the Cell Counting Kit-8 (CCK8) 
sensitive colorimetric assay. (B) The mRNA expression levels of SIX1, E6 and E7 
decrease in HKc/HPV16 and HKc/DR transfected with a plasmid encoding anti-SIX1-
shRNA. Real-time PCR analysis for SIX1, E6 and E7 mRNA in HKc/DRd-1 and 
HKc/DRd-2 cell lines. Levels of expression were normalized to GAPDH. (C) The protein 
expression level of p53 increases while levels of Rb decrease in HKc/DRd-1 cell line 
transfected with SIX1-shRNA plasmid. ELISA for p53 and Rb in HKc/DRd-1 transfected 
with either control (anti-scram shRNA) or anti-SIX1 shRNA at indicated plasmid 
concentrations. (D, E) Loss of SIX1 affects cell viability in HKc/DRd-1. Fluorescent and 
phase-contrast images depicting transfection efficiency and morphology, respectively, of 
HKc/DRd-1 cells 48 hours (top) and 4 days (bottom) post-transfection with anti-SIX1 
shRNA plasmid. (E) Fluorescent and phase-contrast images depicting transfection 
efficiency and morphology, respectively, of HKc/DRd-1 cells 48 hours (top) and 4 days 
(bottom) post-transfection with control-shRNA and scrambled-shRNA plasmids. Images 








Figure 2.2 HKc/DR infected with four different shRNA constructs targeting human SIX1 
gene. mRNA and protein expression levels of SIX1, E6 and E7 in HKc/DRd-1 cells 
infected with four different shRNA constructs targeting four different positions within the 
human SIX1 mRNA sequence. (A) Real-time PCR analysis of SIX1, E6 and E7 mRNA 
in HKc/DRd-1 cell lines. Levels of expression were normalized to GAPDH. (B) ELISA 
for p53 and Rb in HKc/DRd-1 infected with either control (anti-scram shRNA) or the 
indicated anti-SIX1 shRNA constructs. 
 
To fully understand the necessity of SIX1 in these differentiation resistant cell 
lines, HKc/DRd-1 cells were infected with anti-SIX1 shRNA PA317 conditioned 
medium. SIX1 loss was observed in cells treated with all four different constructs with 
concomitant E6 and E7 loss in three of the shRNA constructs (Figure 2.2, A). Similarly, 
in regards to p53 and Rb levels, we observed slight increases in protein levels (Figure 2.2, 
B). Overall, these results indicate that SIX1 expression is vital for cell survival in the 
late-stage HPV16 transformed human keratinocytes. 
 
2.3.2 LOSS OF SIX1 CAUSES DECREASES OF HPV16 E6/E7 mRNA LEVELS IN 
HKc/DR 
The experiments described above also provided a first hint that SIX1 expression 
may affect HPV16 E6/E7 mRNA expression. We have demonstrated that SIX1 
knockdown in HKc/DRd-1 results in the decrease of HPV16- E6/E7 mRNA levels with a 
simultaneous increase in p53 and decrease in Rb protein expression levels (Figure 2.1 B, 
C). Therefore, we set out to further investigate this possibility through transient 
transfections with pre-formed anti-SIX1 siRNA. We utilized two different siRNA 
duplexes targeting different regions of the human SIX1 gene. In HKc/DRd-1 cells, SIX1 
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mRNA levels decreased significantly, under these transient transfection conditions, at 24, 
48 and 72 hours (Figure 2.3, A). Decreased SIX1 expression was associated with 
decreases in HPV16-E6 and E7 mRNA levels (Figure 2.3 B, C). Consistent with a 
decrease of active E6 levels, p53 protein levels increased significantly, with the greatest 
rise observed 24 hours after SIX1 expression (Figure 2.3, D). Not surprisingly, p53 
mRNA levels (which are high in HPV16-transformed cells) markedly decreased in 
HKc/DR transfected cells with either of the two anti-SIX1 siRNA constructs (Figure 2.3, 
E). Rb protein and mRNA levels followed similar trends, however to a lesser extent 













Figure 2.3 Loss of SIX1 with pre-formed anti-SIX1 siRNAs causes decreases of  
HPV16- E6/E7 mRNA levels in HKc/DR. (A) (B) (C) Real-time PCR analysis for SIX1, 
E6 and E7 mRNA in HKc/DRd-1 under transient transfection conditions at the indicated 
time points. Levels of expression were normalized to GAPDH. (D) (F) Relative protein 
expression of p53 and Rb, respectively, after transfection with pre-formed anti-SIX1 
siRNAs in HKc/DRd-1 cells. p53 and Rb protein expression was detected by ELISA in 
HKc/DRd-1 at indicated 24-hour interval time points. (E) (G) Relative mRNA expression 
of p53 and Rb, respectively, in the HKc/DRd-1 cell line transfected with pre-formed anti-
SIX1 siRNAs. p53 and Rb mRNA were quantified by RT/PCR in HKc/DRd-1 at the 
indicated 24-hour interval time points. Levels of expression were normalized to GAPDH. 
 
Taken together, our data indicate that a loss of SIX1 expression in HKc/DR cells 
is associated with decreased expression of the viral oncogenes E6 and E7. The 






2.3.3 KNOCKDOWN OF E7 RESULTS IN DECREASED mRNA LEVELS FOR SIX1 
Previous unpublished work in our laboratory determined that SIX1 levels could 
be increased dramatically in normal HKc by the expression of HPV-16 E7, and by 
siRNA-mediated inhibition of Rb expression, provided that p53 levels were reduced as 
well by shRNA (Figure 2.4 A, B). We have also overexpressed HPV16 -E7 in HKc/DR 
cells. Increased E7 expression resulted in the subsequent increase of SIX1 and HPV16- 
E6 mRNA (Figure 2.5, A). Concomitantly, Rb and p53 protein levels, respectively, were 
downregulated (Figure 2.5 B-E).  
To better pinpoint the functional consequence of E7 suppression in HKc/DR cells, 
the HKc/DRd-1 cell line was transiently transfected with two different siRNA duplexes 
targeting HPV16 -E7. Cells were then collected for RNA and protein extraction 48 hours 
after transfection. Both siRNAs produced a significant decrease in both E6 and E7 
mRNA levels, up to 70% inhibition (Figure 2.6, A) accompanied by approximately 50% 
decrease in SIX1 mRNA levels (Figure 2.6, B). These changes in E6, E7 and SIX1 
mRNA levels were also associated with the expected changes in p53 and Rb mRNA and 









Figure 2.4 Increased SIX1 RNA expression in normal HKc and HKc/E7-expressing cells. 
(A) Real-time PCR analysis of SIX1 mRNA in normal HKc expressing HPV16E7. SIX1 
mRNA expression was normalized to GAPDH; (B) Real-time PCR analysis for SIX1 and 
Rb mRNA in normal HKc co-transfected with a p53-shRNA plasmid and an anti-Rb 














Figure 2.5 Increased SIX1 and HPV16- E6 mRNA expression in HKc/DR overexpressing 
HPV16 E7 from the pLXSN.neo- E7 vector. (A) Real-time PCR analysis for SIX1 and 
E6 mRNA in HKc/DR expressing HPV16 E7. Levels of expression were normalized to 
GAPDH. (B) (D) Real-time PCR analysis of Rb and p53 mRNA in HKc/DR 
overexpressing HPV16- E7. Levels of expression were normalized to GAPDH. (C) (E) 
ELISA for Rb and p53 protein expression in HKc/DR overexpressing HPV16- E7 with 











Figure 2.6 Knockdown of HPV16-E7 with pre-formed anti-E7 siRNAs results in 
decreased mRNA levels of HPV16-E6 and SIX1. (A) (B) Real-time PCR analysis for E6, 
E7 and SIX1 mRNA in HKc/DRd-1 under transient transfection conditions at 48 hours. 
Levels of expression were normalized to GAPDH. (C) Real-time PCR analysis for p53 
mRNA in HKc/DRd-1 48 hours after transient transfection. p53 expression was 
normalized to GAPDH. (D) (F) ELISA for p53 and Rb protein expression in HKc/DRd-1 
48 hours after transient transfection. (E) Real-time PCR analysis of p53 mRNA in 
HKc/DRd-1 at 48 hours. Rb expression was normalized to GAPDH. 
 
 
Collectively, these data suggest that a loss of E6/E7 expression is associated with 
a decrease in the mRNA levels of SIX1. We tentatively explain these changes with the 






2.3.4 SIX1 KNOCKDOWN IN HKc/DR PROMOTES MESENCHYMAL-EPITHELIAL 
TRANSITION (MET) AND RESETS THE LEVELS OF TGF-Β RECEPTORS 1 AND 2 
We set out to investigate global gene expression during transient SIX1 
knockdown in HKc/DRd-1 cells on Affymetrix GeneChip Human Gene 2.0 ST Arrays. 
Direct, paired comparisons of gene expression were made among four individual clones 
of HKc/DR-SIX1-siRNA1and HKc/DR-control-siRNA, and between HKc/DR-SIX1-
siRNA2 and HKc/DR-control-siRNA. We used Transcriptome Analysis Console (TAC) 
software from Affymetrix to analyze the microarray results. To determine the 
differentially expressed genes in the pairwise comparisons, we used a fold change >1.4 
(up and down) and a P value ˂ 0.01 as cutoff values.  In addition, Ingenuity Pathway 
Analysis (IPA) was performed on the differentially expressed genes. Pairwise 
comparisons identified 2447 differentially expressed genes after treatment with SIX1-
siRNA1: 794 genes were upregulated and 1653 genes were downregulated. 
Correspondingly, 2693 differentially expressed genes were identified after treatment with 
SIX1-siRNA2: 1580 genes were upregulated and 1113 genes were downregulated.  We 
then manually identified common genes between the two siRNA duplexes that were 
associated with a transition towards an epithelial phenotype. We were interested in nine 
genes that were downregulated and four genes that were upregulated through siRNA 





Table 2.2 Expression of EMT-associated genes targeted by SIX1 and TGF-β in HKc/DR. 





Table 2.3 Expression of MET-associated genes targeted by SIX1 and TGF-β in HKc/DR. 








Unsupervised cluster analysis clearly differentiated the SIX1 knockdown cells 
from controls and allowed for the identification of a cluster of genes that best separate the 
two (Figure 2.7 A, B). IPA pathway analysis showed that the pathways most heavily 






Figure 2.7 Gene expression profiles of SIX1 knockdown in HKc/DR involve TGF-β       
signaling, MET and apoptosis. (A) Unsupervised hierarchical clustering of differentially 
expressed genes between HKc/DR control siR (left) and HKc/DR SIX1-siR2 (right). The 
color represents the expression level of a gene above (red), below (green), or at neutral 
(black) the mean expression level of that gene across all samples. Pairwise comparisons 
identified 2693 differentially expressed genes after treatment with SIX1-siRNA2: 1580 
genes were upregulated and 1113 genes were downregulated. (B) Heatmap depicting 
select genes relevant to MET. (C) Illustration of downstream functional effects of gene 
transcripts that are upregulated and downregulated. Canonical pathways and diseases & 
functions that are differentially expressed as a result of SIX1 loss in HKc/DR (1.4 fold 
change up and down; p-value ˂ .01). Ingenuity Pathway Analysis (IPA) indicates 
deregulation of pathways related to invasion, proliferation, migration and apoptosis. 
 
 
Among the many changes within these pathways, we observed a reduction in the 
expression of the mesenchymal-related gene Vimentin (VIM) and an increase in the 
expression of the epithelial-related genes Keratin 15 (K15) and Occludin (OCLN). 
Furthermore, there was an increase in expression of the inflammatory response gene 
prostaglandin-endoperoxide synthase 2, PTGS2 (cyclooxygenase-2, COX-2). There was 
a decrease in the expression of the cell-cell adhesion complex molecule, β-catenin 
(CTNNβ1) (Gumbiner et. al., 2005). We noted a decrease in the pro-survival factor 
epidermal growth factor receptor (EGFR) and its associated ligand, transforming growth 
factor alpha (TGF-α). There was a decrease in the angiogenic matricellular marker 
connective tissue growth factor (CTGF/CCN2) and its downstream signaling effector 
ETS proto-oncogene 1, transcription factor (ETS1) (Geisinger et. al., 2012; Ubink et. al., 
2016). mRNA levels for the markers for invasiveness, matrix metalloproteinase 1 and 9 
(MMP1, MMP9), were also decreased. Lastly, there was a decrease in peroxisome 
proliferator activated receptor gamma (PPARƴ), a ubiquitously expressed gene known to 
regulate differentiation and cell growth (Sarraf et. al., 1999). These microarray data 
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suggest that mesenchymal to epithelial transition is a functional consequence of SIX1 
loss in the late-stages of HPV16-transformed human keratinocytes. 
To validate data from the array analysis we performed real-time PCR on 
HKc/DRd-1 cells treated with SIX1-siRNA2 48 hours after transfection. The mRNA 
levels of K15 and OCLN both increased approximately 2.2-fold while VIM mRNA 
levels decreased approximately 20%. Additionally, there was a significant increase, up 
to 40%, in PTGS2/COX-2. These cells might be experiencing cell stress as a result of 
SIX1 loss; and therefore, they react by increasing levels of inflammatory-response 
genes. While the array data showed a 1.54-fold decrease in β-catenin expression, real-
time PCR results revealed a 3-fold increase in mRNA levels. The shift away from a 
mesenchymal phenotype can be associated with changes that follow a gain in cell-cell 
adherens junctions typically seen in normal epithelial cells and β-catenin is a well-
known epithelial marker. There was a 40% decrease in EGFR mRNA levels following 
transfection. Additionally, there was a 55% and 40% decrease in CTGF/CCN2 and 
ETS1 mRNA levels, respectively. Tumorigenic cells are known to metastasize via blood 
or lymphatic vessels through an increase in the mesenchymal-associated gene 
CTGF/CCN2 (Ubink et. al., 2016).
 
In addition, there was a 70% and 40% decrease in 
MMP1 and MMP9 mRNA levels, respectively. Malignant cells can damage the 
basement membrane thru the increase of proteolytic enzymes such as MMP1 and 
MMP9.
 
Lastly, there was a significant decrease in the proliferation and differentiation 
marker PPARƴ. Therefore, a significant decrease of these EMT-inducing proteins is an 







Figure 2.8 SIX1 knockdown induces markers of MET in HKc/DR. Levels of mRNA 
expression of CTGF, CTNNβ1, EGFR, ETS1, K15, MMP1 and 9, OCLN, PPARγ, 
PTGS2 and VIM were determined by real-time PCR analysis in HKc/DR control siR and 
HKc/DR SIX1-siR2. Data were normalized to GAPDH expression. 
 
 
Last, but not least, microarray data revealed a 1.57-fold increase in TβRI and a 
1.84-fold decrease in TβRII. Real-time PCR confirmed these changes. We analyzed our 
array data to locate gene expression changes that are regulated by TGF-β signaling 
(Figure 2.9). We also identified increases in K15 (1.72 fold) and OCLN (2.11 fold) and 
decreases in Hic1 (1.4), VIM (2.05), CTGF (1.72) and PLAT (3) in response to loss of 




Figure 2.9 SIX1 knockdown in HKc/DR resets the levels of TGF-β receptors 1 and 2. 
Levels of mRNA expression of TGFβRI and TGFβRII were determined by Real-time 





The results shown above, taken together with our prior observation on the role of 
SIX1 in HPV16-mediated transformation, point to the fact that SIX1 expression is 
necessary for growth and survival of differentiation-resistant, HPV16-transformed 
human keratinocytes (HKc/DR) and that these cells do not tolerate a decrease in SIX1 
levels. Given the fact that SIX1 is virtually not expressed in normal adult cells, this gene 
may become a suitable therapeutic target for HPV-driven cancers. 
Deregulation of homeobox genes in cancer results in an out of context activation 
of their development-restricted functions. There have been countless studies identifying 
the link between normal organogenesis and neoplasia. Indeed, they both share many 
pathways and basic molecular processes between them, demonstrating undoubtedly that 
tumorigenesis and progression is an aberrant form of morphogenesis. The oncoprotein 
SIX1 has an important role in the expansion of progenitor cell populations during 
embryogenesis and is essential for the development of numerous organs. This 
transcription factor has been shown to be aberrantly misexpressed in various pediatric 
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and adult cancers. SIX1-induced EMT through TGF-β signaling enhances tumor 
progression, invasion and metastasis in several malignancies. 
Our previous work demonstrated that SIX1 mRNA and protein levels are 
overexpressed in the in-vitro model system, and SIX1 mRNA and protein levels are 
consistently up-regulated during progression from HKc/HPV16 to HKc/DR. We further 
show that SIX1 overexpression in HKc/HPV16 induces a differentiation-resistant 
phenotype, and that SIX1 overexpression in HKc/DR induces tumorigenicity. In the 
current study, we focused on the role of SIX1 as a regulator of growth and 
transformation in HPV16-transformed human keratinocytes. We studied the functional 
consequences of suppressing SIX1 in the late stages of HPV16-transformed human 
keratinocytes. 
In our studies, we utilized shRNA technology to suppress SIX1 expression levels 
in HKc/DR cells, resulting in decreased proliferation and widespread cell death. 
Interestingly, in select transfections, we also detected significant increase in SIX1 
expression levels in comparison to the HKc/DR scrambled shRNA control population. 
However, stable transfections resulted in only transient decreases in SIX1 
expression and inconsistent results, which we attributed to the impression that cell 
populations were rapidly taken over by cells in which SIX1 was still being expressed. 
Therefore, we decided to explore the effects of SIX1 inhibition in transient transfection 
conditions, with pre-formed siRNA.  
Previous studies have demonstrated that the transient inhibition of SIX1 in the 
pancreatic cancer cell line, PANC-1, efficiently results in an 86% decrease of SIX1 
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mRNA (Lerbs et. al., 2017). We utilized two siRNA duplexes targeting the human SIX1 
gene and in doing so, we significantly reduced the mRNA expressions of SIX1, E6 and 
E7 at all three time points tested. There was an initial significant decrease in p53 mRNA 
levels; p53 protein levels increased as a result of SIX1 and E6 loss. Moreover, Rb 
mRNA levels were considerably low at the various time points; however, there were 
increases in Rb protein levels after the suppression of SIX1 and E7 mRNA expression. 
Therefore, with the brief reduction of SIX1 expression, we were able to drastically 
reduce E6 and E7 mRNA levels with the corresponding increases in p53 and Rb protein 
levels. Thus, HPV oncoprotein expression in our cell lines could be modulated by SIX1. 
These results also implied that SIX1 is able to promote malignant transformation and 
growth of infected cervical cells together with the concomitant expression of HPV16-E6 
and E7 (Liu D. et. al., 2014).
 
It has been reported that HPV-E7 plays a role in inducing the expression of SIX1. 
HPV-negative C33a cells have very low SIX1 expression levels but the overexpression 
of E7, not E6, has been shown to induce the expression of SIX1 (Liu D. et. al., 2014).
 
The data described in this paper on the reciprocal regulation of SIX1 and E6/E7 levels 
suggest that SIX1 expression in our cell lines is modulated by HPV oncoproteins, 
specifically HPV16 -E7. These results also imply that E7 relies on SIX1 to continuously 
promote malignant transformation and tumor progression by upregulating SIX1 
expression.
 
Similar to many developmental signaling pathways dysregulated in cancer, TGF-
β signaling is known to be connected to numerous pathologic processes and its function 
during ontogenesis parallels its role in neoplasia (Micalizzi et. al., 2009). TGF-β plays a 
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dual role in tumor formation and is known to be associated with tumorigenesis, 
including the progression of premalignant cervical lesions to invasive cervical cancer 
(Baritaki et. al., 2007). TGF-β is a potent suppressor of tumor growth in normal cells and 
early neoplastic lesions; however, this cytokine promotes invasive migration and 
metastasis in the later stages of tumorigenesis (Micalizzi et. al., 2009; Xu H et. al., 2014; 
Xu H et. al., 2015).
 
We have previously shown that SIX1 modulates TGF-beta signaling 
by decreasing canonical (Smad-mediated) responses and increasing non-canonical TGF-
beta signaling pathways in HKc/HPV16 and HKc/DR cell lines (Xu H et. al., 2014; Xu 
H et. al., 2015).
 
Therefore, we analyzed signaling pathways in response to SIX1 
knockdown in HKc/DR and observed alterations in the TGF-β pathway, including 
diminished expression of EGFR and its associated ligand TGF-α, CTGF and its 
downstream signaling effector ETS1, as well as MMP1 and MMP9. Further, the loss of 
SIX1 in HKc/DR results in enhanced expression of TβRI and a reduction in TβRII. 
Taken all together, these findings further confirm that SIX1 plays a very important role 
during progression of HPV16-transformed human keratinocytes- toward a malignant 
phenotype.
 
The effects of SIX1 knockdown, taken all together, corroborated and confirmed 
our prior observations made on the same cells, HKc/DR (and HKc/HPV16) in which we 
overexpressed SIX1, with major effects noted on pathways of EMT/MET, mainly 
through TGF-β signaling (Xu H et. al., 2014; Xu H et. al., 2015). The central EMT 
modulator, TGF-β, has a dual role in tumor development as well as in our cell lines 
where it switches from growth suppressive to EMT-inducing in the progression of HPV-
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mediated transformation of human keratinocytes (Kowli et. al., 2013; Xu H et. al., 2014; 
Xu H et. al., 2015).
 
TGF-β signaling is a critical pathway in which SIX1 overexpression promotes 
EMT in HKc/DR cells. TGF-β receptors type I (TβRI), II (TβRII), and III (TβRIII) are 
part of the TGF-β pathway cascade. Microarray data revealed a 1.57-fold increase in 
TβRI and a 1.84-fold decrease in TβRII in HKc/DR in which SIX1 expression was 
downregulated by our siRNA approach. Real-time PCR demonstrated similar results 
with an approximate 70% increase in TβRI mRNA levels and a 30% decrease in TβRII 
mRNA levels. This may indicate that a decline in SIX1 expression permits HKc/DR 
cells transition from a differentiation resistant phenotype, with mesenchymal features, 
towards a phenotype associated more closely with epithelial cells such as the 
representation of TGF-β as a growth suppressive cytokine. The changes in the 
expression of genes targeted by TGF-β are consistent with our interpretation that a shift 
in TGF-β signaling from non-canonical to canonical, the opposite of what we detected 
with SIX1 overexpression, occurs as a consequence of SIX1 loss.  
As we have previously demonstrated, this shift is pivotal to produce the DR 
phenotype and to further promote tumorigenicity in HPV-transformed cells (Xu H et. al., 
2014; Xu H et. al., 2015). 
 
Based upon our previous body of work elucidating the 
mechanisms of TGF-β control of transcription from the HPV16 URR, we postulate that 
the “shift” in TGF-β signaling from non-canonical to canonical, which we observed as a 
consequence of inhibition of SIX1 expression, may be at the basis of the decrease in 
E6/E7 expression. However, the specific mechanisms by which SIX1 and E6/E7 regulate 
each other remain to be fully elucidated. 
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The decrease in EGFR expression is also of considerable interest. While we can 
explain it as a consequence of decreased E6 levels and increasing p53 levels, this 
observation not only corroborates our overall interpretation of an interplay between 
E6/E7 and SIX1 and a pivotal role of SIX1 in HPV16-mediated transformation and 
tumor progression (Bheda et. al., 2008). 
 
EGFR loss has important functional 
consequences, as malignant cells are known to escape suspension-induced cell death 




















SIX1 OVEREXPRESSION EXTENDS THE LIFESPAN OF NORMAL 




Sine oculis homeobox homolog 1 (SIX1) is a homeodomain-containing 
transcription factor that has a critical role in the expansion of progenitor cells during 
embryogenesis (Coletta et. al., 2008).
  
SIX1 promotes tumor progression by induction of 
epithelial-mesenchymal transition (EMT). SIX1 overexpression has been found in 
various human cancers, including those of the breast, ovary, cervix and liver (Abate-
Shen, 2002; Kumar JP, 2009). In HPV16-transformed human keratinocytes (HKc), SIX1 
overexpression produces EMT and a differentiation-resistant phenotype at early stages of 
in-vitro progression, and transforms cells to malignancy at late stages (Xu H et. al., 2014; 
Xu H et. al., 2015).
 
 
Many studies have shown that inappropriate expression of embryonic genes, 
particularly homeodomain transcription factors, contributes to tumorigenesis and/-or 
tumor progression (Abate-Shen, 2002). In fact, genes critical for normal development are 
often exploited by neoplastic lesions. The homeobox gene SIX1 encodes an embryonic 
transcription factor broadly expressed during development in different tissues and organs, 
including muscle, the auditory system, olfactory system and kidney, where it plays a 
 
48 
critical role (Coletta et. al., 2010). The overexpression of SIX1 in cancer cells is 
associated with tumor progression and metastasis, and decreased survival, mirroring its 
developmental roles (Behbakht et. al., 2007). 
SIX1 overexpression in immortalized and nontumorigenic mammary epithelial 
cells and in premalignant HPV16-transformed cells in our model system induces 
malignant transformation, leading to tumor formation in nude mice (McCoy et. al., 
2009). SIX1 is overexpressed in 50% of primary mammary carcinomas and 90% of 
metastatic lesions (Reichenberger et. al., 2005). Additionally, SIX1 overexpression in 
human breast cancer cell lines induces EMT and metastasis (Kumar JP, 2009; McCoy et. 
al., 2009). 
 
SIX1 overexpression correlates with increased tumor malignancy and lymph 
node metastasis (Zheng et. al., 2010). 
 
Moreover, SIX1 overexpression is significantly 
associated with poorer overall survival in advanced-stage colorectal cancer (CRC) (Ono 
et. al., 2012). 
The overexpression of SIX1 has been extensively studied in cancer and cancer-
derived cells. In fact, SIX1 overexpression has been shown in immortalized mammary 
epithelial cells to induce malignant transformation, leading to aggressive and invasive 
tumors when injected into nude mice (Coletta et. al, 208). Furthermore, McCoy E. L. et. 
al., 2009 have generated a transgenic mouse model that expresses the human SIX1 gene 
in the mouse mammary epithelium. SIX1 expression in these non-transformed mammary 
glands of mice induces tumors and increases the mammary stem cell population. 
However, the ability of SIX1 to initiate malignant transformation in normal primary 
human cells have yet to be investigate. Hence, we set out to investigate the biological 
consequences of SIX1 overexpression, in-vitro, in primary normal HKc. 
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The focus of the present study was to explore the functional consequences of 
SIX1 overexpression, alone or in combination with the overexpression of HRas-V12 and 
an anti-p53 shRNA, in normal HKc. HKc/SIX1 and HKc/ALL3 grew continuously past 
the end of the normal HKc lifespan and exhibited a spindle-shape and fibroblastic 
appearance, rather than the cuboidal morphology of epithelial cells. Moreover, the growth 
rates of HKc/SIX1 and HKc/ALL3 were comparable to those of early-stage HPV16-
immortalized HKc (HKc/HPV16). The invasiveness of HKc/SIX1 was comparable to 
that of HKc/HPV16 and the invasiveness of HKc/ALL3 is greater than HKc/DR. Finally, 
using microarrays, we demonstrated that SIX1 overexpression induces EMT in normal 
keratinocytes. Overall, our data demonstrate that SIX1 facilitates the establishment of 
primary human keratinocytes into cell lines with an extended lifespan, or perhaps into 
stem-like cells, and induces epithelial-mesenchymal transition. 
 
3.2 MATERIALS AND METHODS 
Cell culture and treatment 
The cell lines, HKc/HPV16-d1 and HKc/DRd-1, discussed in this work have been 
previously described (Pirisi et. al., 1987; Pirisi et. al., 1988). 
 
Normal HKc were 
maintained in keratinocyte serum-free medium supplemented with epidermal growth 
factor (EGF) and bovine pituitary extract, BPE (KSFM, Invitrogen, Carlsbad, CA). HFb 
were cultured in Dulbecco’s modified eagle’s medium containing 4500 mg/L glucose, L-
glutamine, sodium pyruvate and sodium bicarbonate (DMEM, Invitrogen). HKc/HPV16-
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d1, HKc/DRd-1 and normal HKc cells were maintained in a humidified atmosphere of 
5% CO2 at 37 
o
C. HFb was maintained in a humidified atmosphere of 10% CO2 at 37 
o
C. 
Plasmid constructs and stable transfection 
First or second passage normal HKc and HFb at 70% confluency were transfected 
with either a pcDNA3.1/Zeo plasmid encoding human-SIX1 or a combination of three 
plasmids: pcDNA3.1/Zeo-SIX1, a pBABE/puro plasmid encoding HRas-V12 and a 
pSUPER/puro plasmid encoding a p53 shRNA. For transfection efficiency, the 
pSUPER/puro plasmid encoding the GFP reporter gene was used. As a vector control, the 
pSUPER/puro plasmid was used. Normal HKc and HFb were transfected with 
Lipofectamine 3000 (Invitrogen) following the manufacturer’s instructions. Stable 
transfectants, HKc/SIX1, HKc/ALL3, HFb/SIX1 and HFb/ALL3, were selected in          
50 ug/mL Zeocin (Invitrogen) and/or 3 ug/mL Puromycin (Toku-E). 
RNA interference (RNAi) 
HKc were transfected with two different anti-SIX1 siRNA or anti-GFP siRNA 
(control) duplexes using Lipofectamine RNAiMAX (Invitrogen) following the 
manufacturer’s instructions. The protocol for transient transfections have been previously 
described (Chapter 1). 
Real-time PCR 
Total RNA was isolated from cells using the RNeasy Plus Micro Kit (Qiagen, 
Hilden, Germany). Reverse transcription was carried out with 1 μg of total RNA using 
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Real-time PCR was performed 
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using iQ SYBR Green Supermix (Bio-Rad). All procedures were followed according to 
the manufacturer’s instructions. The sequences of the primers used for real-time PCR 
have been previously listed (Chapter 1, Table 2.1). GAPDH was used as an internal 
control. All samples were assayed in duplicates. 
Droplet digital PCR (ddPCR) for HRas-V12 mutation detection 
  Genomic DNA (gDNA) was isolated from cells using the AllPrep DNA/RNA 
mini kit (Qiagen). Detection, amplification and quantitation of HRas-V12 was performed 
by ddPCR, using the QX200 system (Bio-Rad) and probe-based assays (HRas p. G12V 
and HRas WT for p. G12V PrimePCR ddPCR Mutation Detection Assays; Bio-Rad and 
custom designed). All procedures were performed according to the manufacturer’s 
instructions. The PCR mixture contained 12.5 μl of ddPCR droplet supermix for probes 
(no dUTPs), 1.25 μl of mutation primer/probe mix (FAM), 1.25 μl of wild type 
primer/probe mix (HEX) and 5 μl of gDNA (digested with MseI and diluted 1:10) in a 
final volume of 25 μl. Twenty-five microliters of this mixture and 70 μl of droplet 
generation oil were transferred to different wells of a droplet generation cartridge. After 
formation of droplets using the droplet generator, samples were transferred to a 96-well 
PCR plate. Plates were sealed at 180 °C using pierceable foil heat seal and a PX1 PCR 
plate sealer (Bio-Rad). Samples were subjected to PCR amplification for 40 cycles at 
94°C for 30 secs and 55°C for 60 secs. Droplets were analyzed on the droplet reader, and 
Quantasoft software (version 1.4.0.99) was used for analyzing DNA concentrations. 
Threshold lines for each primer/probe mix, which divides the positive and negative 
droplets unequivocally, were determined and applied equally to all the samples. 
Experiments contained control samples, such as wild type gDNA, mutant HRas-V12 
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plasmid and no template. All samples were assayed in duplicates with at least three 
biological replicates. 
Enzyme-linked immunosorbent assay (ELISA) 
Protein was isolated from cells using 10x Cell Lysis Buffer (Cell Signaling, 
Danvers, MA).  The extracted supernatant included a protease inhibitor (Sigma, Saint 
Louis, MO). PathScan Total p53 Sandwich kit and PathScan Total Rb Sandwich kit were 
used. Test procedure utilizing total protein was performed according to the 
manufacturer’s instructions. 50 ug/ml of protein was loaded into the p53 pre-coated 
wells. 150 ug/ml of protein was loaded into the Rb pre-coated wells. All samples were 
assayed in replicates of two or three. Absorbance was read at 450 nm within 30 minutes 
using a microplate reader. 
Cell proliferation assay 
The growth rates of HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16-d1 and 
HKc/DRd-1 were compared. Proliferation, at 24-hour intervals, was determined at 
different passage numbers through the Cell Counting Kit-8 (CCK8) sensitive colorimetric 
assay utilizing the WST-8 dye reagent (Dojindo, Rockville, MD). 5,000 cells in 500 ul of 
their respective media were plated per well in 24-well plates. Cells were plated in 
triplicate wells and 50 ul of WST-8 dye solution was added to each well and placed in a 
CO2 incubator for 2 hours for reaction to take place. Absorbance was read at 450 nm 




Cell invasion assay 
The invasive ability of HKc/SIX1 or HKc/ALL3 in comparison with HKc, 
HKc/HPV16-d1 and HKc/DRd-1 was measured using CultreCoat Basement Membrane 
Extract (BME)-Coated Cell Invasion assay (Trevigen, Gaithersburg, MD). Boyden 
chambers (24-well inserts) with an 8.0 μm polycarbonate (PC) membrane were used.  
The top side of the membranes was coated with laminin I, collagen IV, entactin and 
heparin sulfate proteoglycan. The upper surface of the matrix was challenged with 
100,000 cells in complete medium. The lower chamber contained DR medium. After 24 
hours, a mixture of Cell Dissociation Solution/Calcein AM was added to the bottom 
chamber of each well and incubated for 1 hour. The number of invading cells was 
quantified at 485 nm excitation, 520 nm emission with a microplate reader. Each 
experiment was performed in triplicate wells. 
Wound-healing assay 
To compare the migration of HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16-d1 and 
HKc/DRd-1, cells were seeded into 60-mm plates and cultured until near confluency. 
Then, the cell monolayer was scraped with a 200-uL pipette tip through the central axis 
of the plate to generate artificial wounds. The wound distances were measured at 0, 4, 8, 
12 and 24 hours under the microscope at 40X magnification. Images were captured in at 
least five different fields. The experiments were performed in triplicates. 
Clonogenic assay 
To compare the ability of a single cell to grow into a colony 50,000 cells of HKc, 
HKc/SIX1 and HKc/ALL3 were seeded onto 100-mm
2
 plates and cultured for 10 days. 
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They were then washed twice with PBS, fixed in methyl acetate for 10 minutes and 
stained with 10% Giemsa (Thermo Fisher Scientific, Waltham, MA) to evaluate colony 
size. Experiments were performed in triplicate, and colonies with at least 50 cells 
(cells ≥ 1 mm in diameter) were enumerated by ImageJ software (NIH, Washington, 
D.C.) and compared between the different groups. 
Population doubling (PD) and total cell output 
To compare the replicative capacity between HKc and HKc/SIX1 or HKc/ALL3, 
50,000 cells were seeded onto 100-mm
2
 plates and cultured for 10 days. Cells were 
passaged and re-plated every 10 days up to 40 days. Experiments were performed in 
triplicate and generation time was calculated with the following equation:    
     duration * log (2)  
  ----------------------------------------------------------------------     
    Log (Final concentration) – Log (Initial concentration) 
 
The same dataset was utilized to calculate the total cellular output of cells 
between HKc and HKc/SIX1 or HKc/ALL3. In general, the average number of cells after 
each time point (every 10 days) was subtracted from the initial number of seeded cells 
(5x10
4
). Experiments were performed in triplicate. 
Sphere-formation assay 
To determine whether HKc/SIX1 and HKc/ALL3 exhibit anchorage-
independence, spheroid-forming ability was tested. 96-well plates were coated with     





cells/ml) were suspended as a single-cell suspension. After 24 hours, spheroids 
were photographed on a Nikon TMS phase microscope using Infinity 1 Analyze 
software. Each experiment was repeated in replicates of two or three. 
Gene-expression microarray analysis and validation by SYBR green real-time PCR 
To correlate the genes and pathways that are affected in comparison with those 
that are affected when SIX1 is suppressed in HKc/DR cells, we utilized the gene 
expression array analysis from our previous study (Chapter 1). 
Statistical analysis 
Results were expressed as the mean ± standard deviation (SD). Data were 
interpreted using student’s t-test. P ≤ 0.05, P ≤ 0.01 or P ≤ 0.001 were considered 
statistically significant and indicated in the figures by *, ** or ***, respectively. 
 
3.3 RESULTS 
3.3.1 OVEREXPRESSION OF SIX1 IN NORMAL HKc 
To investigate the behavior of SIX1 in normal HKc, we set out to explore the 
effects of stably overexpressing SIX1 alone or in combination with HRas-V12 and p53i. 
Normal HKc and normal HFb were transfected with either a pcDNA3.1/Zeo plasmid 
encoding human-SIX1 or a combination of three plasmids: pcDNA3.1/Zeo-SIX1, a 
pBABE/puro plasmid encoding HRas-V12 and a pSUPER/puro plasmid encoding a p53 
shRNA that we had previously demonstrated to be specific and selective (Bheda et. al., 
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2008). Transfection efficiency was monitored with the co-transfection of the 
pSUPER/puro plasmid (3:1 w/v), expressing GFP (Figure 3.1, A). Real-time PCR 
confirmed that the mRNA levels of SIX1 were overexpressed in normal HKc (Figure 3.1, 
B). SIX1 mRNA levels in HKc/SIX1 were comparable to HKc/DR cells while the 
HKc/ALL3 cells were approximately 2.3-fold greater than the HKc/DR line. To compare 
mutant-to-wild type allele ratio of ras, primer/probe sets specific for each allele were 
utilized in ddPCR. The specificity of these primer/probe sets was shown with 
pBABE/puro. HRas-V12 plasmid as the positive control (Figure 3.2, A). Utilizing 
ddPCR, Ras-V12 to wild type ras ratios from equimolar amounts of genomic DNA 
of HKc, HKc/ALL3, HKc/HPV16 and HKc/DR were detected. Ras-V12 was observed in 
HKc/ALL3 and HKc/DR compared to HKc/HPV16 and HKc, which served as the 
negative control (Figure 3.2, B). 
 
 
Figure 3.1 The expression of SIX1 significantly increases in normal HKc transfected with 
a SIX1 expression vector. (A) Representative image of successfully transfected cells. 
Normal HKc transfected with pcDNA3.1/Zeo-SIX1; a combination of pcDNA3.1/Zeo-
SIX1pBABE/puro HRas-V12 and pSUPER/puro-p53 shRNA; or pSUPER/puro vector 
control plasmid, and co-transfected with GFP (3:1 w/w) to monitor transfection 
efficiency. GFP expression was analyzed 24-48 hours post-transfection at 200X 
magnification. (B) Real-time PCR analysis for SIX1 mRNA in normal HKc transfected 






Figure 3.2 The expression levels of HRas-V12 in HKc/SIX1 and HKc/ALL3. 
(A) Experimental validation.1D-Dot plot. The blue histogram indicates the number of 
droplets considered as positive for mutant Hras-V12 according to the fluorescence 
threshold. The green histogram corresponds to the number of wild-type droplets. Mutant 
control, DNA containing a 1:1 mix of mutant and wild type Hras-V12. WT control, DNA 
containing only KRAS wild-type. Blank, water, no template control. (B) Detection 
threshold of Hras-V12 from gDNA using ddPCR. 2D-Dot plot. Fluorescence results are 
plotted as two-dimensional dot plots (similar to the depiction of flow cytometry data). 
The region of these plots can be sequentially separated based on the fluorescence 
intensity of each droplet. Grey dots correspond to empty droplets. Green dots correspond 
to droplets containing wild-type copies of Hras. Blue dots correspond to droplets 
containing Hras-V12 mutation. Each analysis was performed in duplicate. Experiments 
were repeated at least three times. Nhkc contains no trace of mutant Hras-V12. 





Additionally, HKc and HFb cells transfected with the plasmids encoding SIX1, 
HRas-V12 and p53i were tested for contamination with the HPV16-E6 and E7 viral 
oncogenes. HKc/SIX1, HKc/ALL3, HFb/SIX1 and HFb/ALL3 were shown to not be 
contaminated with HPV DNA (results not shown). 
 
3.3.2 SIX1 DOWNREGULATES p53 IN HKc/SIX1 
Once we confirmed the robust SIX1 expression in SIX1-transfected HKc, we next 
explored the levels of the tumor suppressor genes p53 and Rb. p53 mRNA expression 
levels were decreased by more than 70% in both HKc/SIX1 and HKc/ALL3 cells (Figure 
3.3, A). The levels of p53 were significantly smaller than those in the HKc/HPV16 and 
HKc/DR cell lines. p53 protein expression levels in HKc/SIX1 and HKc/ALL3 were 
decreased approximately 60% in comparison to HKc and their protein levels were smaller 
in comparison to the HKc/HPV16 and HKc/DR cell lines (Figure 3.3, B). 
We next examined Rb mRNA levels in our transfected cell lines. Rb mRNA 
expression was significantly increased in HKc/SIX1 and HKc/ALL3 (Figure 3.3, C). 
There was a slight decrease in Rb protein levels in HKc/SIX1 with a slight increase in 
HKc/ALL3 (Figure 3.3, D). Similarly, we have previously demonstrated that the 
simultaneous knockdown of p53 and Rb in HKc results in the increase of SIX1 mRNA 





Given that SIX1 modulates p53 and Rb mRNA expression levels, we set out to 
assess levels of p53 and Rb after the transient knockdown of SIX1 in HKc. We 
demonstrated a significant reduction in p53 and Rb mRNA levels with a concomitant 
reduction in respective protein levels, in cells treated with anti-SIX1 siRNA (Figure 3.4). 
Collectively, we conclude that SIX1 regulates the expression of the p53 and Rb tumor 
suppressor genes. Pathways that are affected in response to the expression of the SIX1 





Figure 3.3 The expression levels of p53 and Rb in HKc/SIX1 and HKc/ALL3. (A) Real-
time PCR analysis of p53 mRNA in normal HKc. p53 expression was normalized to 
GAPDH. (B) ELISA for p53 protein expression in normal HKc. (C) Real-time PCR 
analysis of Rb mRNA in normal HKc. Rb expression was normalized to GAPDH. (D) 








Figure 3.4 The expression of p53 and Rb decrease in normal HKc transfected with              
pre-formed anti-SIX1 siRNAs. Real-time PCR analysis for SIX1, p53 and Rb mRNA in 
SIX1-expressing HKc. Levels of expression were normalized to GAPDH; ELISA for p53 










3.3.3 HKc/SIX1 AND HKc/ALL3 DISPLAY AN EXTENDED LIFESPAN AND 
RESISTANCE TO SERUM AND CALCIUM-INDUCED DIFFERENTIATION 
A distinct feature of SIX1 overexpression in normal HKc was the continuous 
growth of HKc/SIX1 and HKc/ALL3. pSUPER vector-transfected controls senesced. 
Continuous growth past the end of the normal lifespan was also observed in HFb/SIX1 
and HFb/ALL3. We have previously demonstrated that normal HKc and HKc/HPV16 
can be cultured in conditions containing serum-free media and low Ca
2+
, whereas media 
containing high-calcium or serum elicits terminal differentiation (Pirisi et. al., 1988; Xu 
H et. al., 2015).
 
One of the features of HKc/DR is resistance to serum and calcium-
induced differentiation (Xu H et. al., 2015). We investigated whether the expression of 
exogenous SIX1 in HKc/SIX1 and HKc/ALL3 induces differentiation resistance. Both 
HKc/SIX1 and HKc/ALL3 grew well in media supplemented with either 5% or 10% fetal 
bovine serum (FBS) and 1mM CaCl2 while HKc/DR grow best in similar media 
containing 5% FBS. The results indicate that SIX1 generates differentiation resistance in 
cells. In addition, HKc/SIX1 and HKc/ALL3 exhibited a spindle-shaped and fibroblastic 
appearance (Figure 3.5, A). However, these epithelial cells remain morphologically 
distinct from SIX1-overexpressing normal HFb (Figure 3.5, B). The extended lifespan of 
HKc/SIX1 and HKc/ALL3 ultimately ended with senescence by passage 30, with or 
without the supplementation of serum and calcium. These data suggest that SIX1 







Figure 3.5 Morphological changes due to SIX1 overexpression in normal HKc and HFb. 
(A) Cell morphology of normal HKc, HKc/SIX1 and HKc/ALL3. Images are shown at 
200X magnification. (B) SIX1 overexpression in normal HFb. Cell morphology of 
normal HFb, HFb/SIX1 and HFb/ALL3. Images are shown at 200X magnification. 
 
 
3.3.4 SIX1-EXPRESSING CELLS ARE CULTURED FROM KERATINOCYTES AND 
EXHIBIT EPITHELIAL FEATURES, DESPITE THEIR FIBROBLASTIC 
MORPHOLOGY 
During the beginning stages of foreskin processing, a necessary step is the 
separation of the dermis from the epidermis. To verify that the SIX1-expressing epithelial 
cells were of keratinocyte origin, we compared mRNA levels of E-cadherin, Fibronectin, 
N-cadherin, SNAIL, TWIST and Vimentin (VIM) with that of non-transfected HFb. We 
also analyzed expression levels of Keratin 14 (K14), an epidermal gene, as well as 
Keratin 19 (K19), a transformation marker. There were nominal levels of E-cadherin in 




transition. There were significant expression of the mesenchymal markers Fibronectin 
and N-cadherin but their mRNA levels were smaller in comparison to HFb (Figure 3.6). 
HKc/SIX1 and HKc/ALL3 seem to demonstrate an intermediate “metastable” state of 
EMT. There was a significant increase in TWIST but not in SNAIL for the HKc/SIX1 
and HKc/ALL3 cells. Moreover, there was a significant increase in the mesenchymal 
marker VIM in the HKc/SIX1 cells. HKc/SIX1 seems to demonstrate a more advanced 
metastable stage of EMT in comparison to HKc/ALL3. Lastly, mRNA expression levels 
of K14 were nominal in the SIX1-expressing cells, perhaps due to EMT, and K19 levels 











Figure 3.6 Expression of epithelial and mesenchymal-associated genes in SIX1-
expressing normal cells. The levels of mRNA expression of E-cadherin, Fibronectin, N-
cadherin, TWIST, SNAIL, VIM, K14 and K19 were determined by real-time PCR 
analysis in normal HKc, normal HFb, HKc/SIX1 and HKc/ALL3. Data were normalized 
to GAPDH expression. 
 
 
3.3.5 INCREASE IN SIX1 INDUCES ALTERATIONS IN GROWTH, INVASION 
AND MIGRATION IN HKc/SIX1 AND HKc/ALL3 
To further elucidate the functional role of SIX1 in HKc, we proceeded to 
demonstrate their proliferative capacity and invasive ability. The growth rates of 
HKc/SIX1 and HKc/ALL3 were comparable to the HKc/HPV16 cells (Figure 3.7, A). 
We also demonstrated that as the passage number increased, the proliferative capacity of 
HKc/SIX1 and HKc/ALL3 increased. Moreover, invasion assays demonstrated that 
HKc/SIX1 is more invasive than normal HKc, and their invasiveness is comparable to 
that of HKc/HPV16. The invasiveness of HKc/ALL3 is greater than the HKc/DR cells, 
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which are about 2.5-fold more invasive than HKc/HPV16 (Figure 3.7, B). Additionally, 
we demonstrated that as the passage number increased, the invasive abilities of our SIX1-
expressing cell lines increased as well. 
Given that the SIX1-expressing cells presented an enhanced rate of proliferation 
and invasion, we set out to explore their migratory potential by utilizing a wound-scratch 
assay. Furthermore, HKc/SIX1 and HKc/ALL3 restored 77% and 79%, respectively, of 
the wounded area within 24 hours in culture (Figure 3.7 C, D). Their rate of wound 
closure fell in-between that of HKc/HPV16 and HKc/DR (Table 3.1). These results 
further validate that HKc/SIX1 and HKc/ALL3 exhibit a mesenchymal phenotype and 
















Figure 3.7 SIX1 overexpression induces alterations in growth, invasion and migration in        
normal HKc. (A) Cell proliferation was determined by the Cell Counting Kit-8 (CCK8) 
colorimetric assay utilizing the WST-8 dye reagent at the days indicated in normal HKc, 
HKc/SIX1, HKc/ALL3, HKc/HPV16 and HKc/DR.  (B) Invasion assays for normal 
HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16 and HKc/DR. Basement membrane extract 
(BME) cell invasion as determined by transwell migration. Quantification of invading 
cells was determined by the addition of calcein AM after 24 hours. (C) Percentage of 
wound closure after a scratch in normal HKc, HKc/SIX1, HKc/ALL3, HKc/HPV16 and 
HKc/DR at the time points indicated. (D) Scratch-wound assay depicting the migratory 





Table 3.1 Percentage of wound closure between NHKc, HKc/SIX1, HKc/ALL3, 





3.3.6 SIX1-EXPRESSING EPITHELIAL CELLS DISPLAY HIGH CLONAL 
GROWTH AND INCREASED REPLICATIVE CAPABILITY 
To assess the ability of HKc to form colonies, 5x10
4 
cells were plated in 100-mm
2 
dishes and sub-cultured for 10 days. Normal HKc were used as controls. HKc/SIX1 and 
HKc/ALL3 demonstrated more robust colony formation, more than 3-fold, in comparison 
to HKc (Figure 3.8, A; Table 3.2). Additionally, HKc/SIX1 and HKc/ALL3 both 
underwent nearly 24 population doublings (PD) within 40 days in culture, compared to 
the 9 PD acquired by HKc (Figure 3.8, B; Tables 3.3, 3.4). The approximate doubling 
time of HKc/SIX1 and HKc/ALL3 was between 48-60 hours in comparison to the 
doubling time of 72 hours in normal HKc. Lastly, the total concentration of cells in 
HKc/SIX1 and HKc/ALL3 were up to 14- and 16- fold greater, respectively, than normal 
HKc after 30 days in culture (Figure 3.8, C; Table 3.5). These findings suggest that SIX1-
expressing epithelial cells have the increased capacity to replicate and produce a 




Figure 3.8 HKc/SIX1 and HKc/ALL3 display high colony density and increased  
replicative capability. (A) 5x10
4 
cells were plated in 100-mm
2 
dishes, sub-cultured and 
colony patterns were examined by Giemsa staining after 10 days. Normal HKc, 
HKc/SIX1 and HKc/ALL3 after 10 days in culture. (B) Cumulative population doublings 
(PD) observed in HKc/SIX1 and HKc/ALL3 relative to normal HKc over the course of 
40 days. (C) Total cell output in HKc/SIX1 and HKc/ALL3 relative to normal HKc over 










Table 3.2 Clonal growth of NHKc, HKc/SIX1 and HKc/ALL3 10 days in culture. 
Significant increase in dish occupancy of HKc/SIX1 and HKc/ALL3 relative to normal 
HKc after 10 days in culture. Cells were manually counted and quantified by ImageJ 




Table 3.3 Cumulative population doublings NHKc, HKc/SIX1 and HKc/ALL3. 
 
 
Table 3.4 Estimated doubling times of NHKc, HKc/SIX1 and HKc/ALL3. 
 
 
Table 3.5 Total cell output between NHKc, HKc/SIX1 and HKc/ALL3 over the course of 









3.3.7 HKc/SIX1 AND HKc/ALL3 SURVIVE IN SUSPENSION CULTURE 
To understand whether HKc/SIX1 and HKc/ALL3 have the capability to evade 
programmed cell death upon loss of adhesion to a monolayer culture substrate, we 
utilized a spheroid culture model containing a mixture of agarose and KSFM to 
investigate their spheroid forming abilities. HKc/SIX1 and HKc/ALL3 had the capability 
to aggregate into multicellular spheroids (Figure 3.9 A, B). Furthermore, when the 
suspended spheroids were transferred from the spheroid culture back to a monolayer 
culture, they readily adhered and began proliferating (Figure 3.9 C-F). These findings not 
only demonstrate that SIX1-expressing keratinocytes can overcome suspension-induced 
cell death (anoikis), accumulate and assemble into spheroids in a suspension culture, they 
remain functionally viable (up to at least eight passages) once re-plated from the spheroid 
culture back into a monolayer culture (Woappi Y et. al., 2017).
 
In addition, spheroid-
derived HKc/SIX1 and HKc/ALL3 returned to a cobblestone-type morphology when re-
plated in monolayers. 
3.3.8 SIX1 OVEREXPRESSION IN NORMAL HKc PROMOTES EMT 
Due to the changes in cellular morphology and behavior, such as growth and 
invasion, in HKc/SIX1 and HKc/ALL3, we set out to investigate the expression of EMT 
related genes. This study explored the effects of SIX1 overexpression in normal HKc on 
global gene expression through the utilization of Affymetrix GeneChip Human Gene 2.0 
ST Arrays. We used Transcriptome Analysis Console (TAC) software from Affymetrix 
to analyze the microarray results. We were interested in the same set of genes as our 
paper (Chapter 1) that discussed the role of SIX1 knockdown on global gene expression 
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in HKc/DR cell lines. To determine the differentially expressed genes from the 




Figure 3.9 HKc/SIX1 and HKc/ALL3 survive in suspension culture. (A) HKc/SIX1 in 
spheroid (B) HKc/ALL3 in spheroid (C) (D) HKc/SIX1 at eight passages after 
suspension culture. 40X and 100X, respectively. (E) (F) HKc/ALL3 at 24 hours after 




















The following images (Figure 3.10; Tables 3.6, 3.7) demonstrate the differentially 
expressed genes that were either upregulated or downregulated in HKc/SIX1 and 
HKc/ALL3. Based on our microarray data from our original paper (Chapter 1), we 
analyzed the following set of genes, which included EMT-associated genes regulated by 
TGF-β (Wendt et. al., 2009): connective tissue growth factor (CTGF/CCN2),                  
β-catenin (CTNNβ1), ETS proto-oncogene 1, transcription factor (ETS1), Keratin-15 
(K15), Occludin (OCLN) and TGF-β receptors type I and II (TβRI, TβRII). We also 
investigated the epidermal proliferation gene, ki-67, and epidermal growth factor 
receptor, EGFR. To validate the array data, we performed real-time PCR. In the 
HKc/SIX1 and HKc/ALL3 cells, we observed an increase in the angiogenic matricellular 
marker CTGF and a reduction in its downstream signaling effector ETS1 (Ubink et. al., 
2016; Geisinger et. al., 2012). HKc/SIX1 displayed significant increases in expression of 
the inflammatory response gene prostaglandin-endoperoxide synthase 2, PTGS2 
(cyclooxygenase-2, COX-2). There were significant increases in peroxisome proliferator 
activated receptor gamma (PPARγ), a ubiquitously expressed gene known to regulate 
differentiation and cell growth (Sarraf et. al., 1999). 
Additionally, there was a decrease in the expression of the cell-cell adhesion 
complex molecule CTNNβ1 (Gumbiner et. al., 2005).  As expected, we observed a 
reduction in the expression of the epithelial-related genes K15 and OCLN. We noted an 
increase in the pro-survival factor EGFR. Lastly, we noted an increase in ki-67 mRNA 


















Figure 3.10 SIX1 overexpression in normal HKc promotes EMT. Levels of mRNA 
expression of CTGF, CTNNβ1, EGFR, ETS1, ki-67, K15, OCLN, PPARy and PTGS2 
(COX-2) were determined by real-time PCR analysis in normal HKc, HKc/SIX1 and 







3.3.9 INCREASE IN SIX1 EXPRESSION MODULATES TGF-β RECEPTOR mRNA 
LEVELS IN NORMAL HKc 
We attempted to identify pathways known to dictate SIX1-induced EMT within 
the normal HKc population. TGF-β signaling is a critical pathway in which SIX1 
overexpression promotes EMT in malignant cells. The central EMT modulator, TGF-β, 
is known to exhibit a dual role in tumor development as well as in our HKc/HPV16 and 
HKc/DR cell lines. TGF-β has been shown to switch from growth suppressive to EMT-
inducing in the progression of HPV-mediated transformation of human keratinocytes 
(Wendt et. al., 2009). The majority of genes described here are known to be regulated by 
TGF-β signaling. TGF-β receptors type I (TβRI), II (TβRII), and III (TβRIII) are part of 
the TGF-β pathway cascade. Previous microarray data revealed an increase in TβRI and 
a decrease in TβRII when SIX1 was decreased in the HKc/DR lines (Chapter 1). Real-
time PCR demonstrated similar results. In contrast, when we tested TβRI and TβRII 
mRNA expression levels in HKc/SIX1 and HKc/ALL3 we observed a decrease in TβRI 
and an increase in TβRII (Figure 3.11), similar to what we have observed when we 
increase SIX1 levels in our HKc/HPV16 and HKc/DR cell lines (Xu H et. al., 2014; Xu 















Figure 3.11 SIX1 modulates TGF-β receptor mRNA levels in normal HKc. Levels of 
mRNA expression of TGFβRI and TGFβRII were determined by real-time PCR analysis 





It is well documented that the signaling pathways involved in carcinogenesis 
often represent aberrations of molecular activities that occur during early development. 
Misexpression of embryonic transcription factors are known to lead to carcinogenesis 
(Abate-Shen et. al., 2002). These proteins reestablish developmental programs out of 
context. SIX1 is a developmentally restricted transcription factor that inappropriately 
reinstates numerous embryonic pathways, including growth, proliferation, survival and 
migration during oncogenesis (Kumar et. al., 2009). Indeed, the SIX1 oncofetal protein 
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participates in the regulation of numerous pediatric and adult cancers (Abate-Shen et. al., 
2002; Coletta et. al., 2010; Kumar et. al., 2009). 
Serrano M. et. al., 1997 demonstrated that transformation of primary cells 
by ras requires either an oncogene or the inactivation of tumor suppressors such as p53, 
p21 or p16. Oncogenic ras induces senescence through p53 and p16 in primary human or 
rodent cells; and therefore, inactivation of p53 and/-or p16 prevents ras-induced arrest in 
these cell types that are not transformed nor immortalized (Serrano et. al., 1997). With 
this in mind, we have shown that the overexpression of SIX1 extends the lifespan of 
normal HKc and pushes these cells to become resistant to serum and calcium-induced 
differentiation in culture. SIX1 expression in normal HKc induces a spindle-shaped and 
fibroblastic appearance rather than the known cuboidal morphology of epithelial cells. 
Moreover, HKc/SIX1 and HKc/ALL3 cells demonstrated increases in cell proliferation, 
invasion and migration compared to HKc. 
As a result of SIX1 expression in normal HKc, p53 mRNA and protein expression 
levels were drastically decreased. SIX1 is not implicated to affect levels of p53 until 
Towers et. al., 2015, discovered that SIX1 downregulates p53 through a mechanism that 
involves the direct upregulation of microRNA-27a and the simultaneous downregulation 
of the p53-translational regulator, ribosomal protein L26 (RPL26) (Towers et. al., 2015).
 
Similarly, we have shown that the simultaneous knockdown of p53 and Rb in HKc 
results in the increase of SIX1 mRNA expression levels. Together, these findings 
demonstrate that SIX1 has a relationship with p53 that warrants further investigation. 
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The development of metastatic lesions has been known to contribute to the 
dysregulation of oncogenes and tumor suppressor genes. Li et. al., 2013 have shown that 
silencing of SIX1 decreased phosphorylation levels of Rb in human pancreatic carcinoma 
cell lines (PANC-1). This may explain SIX1 induced hyperproliferation, cell growth and 
cell cycle progression (Li Z et. al., 2013).
 
Similarly, in normal HKc, we have shown that 
overexpressing SIX1 leads to an increased expression of Rb. This tumor suppressor gene 
is known to bind to E2F and inhibit transcriptional regulation by E2F and cell cycle 
progression (Young et. al., 2003). SIX1 expression is known to be regulated by the E2F 
family member E2F1.  The overexpression of SIX1 leads to the deregulation of cell cycle 
checkpoints including E2F (Kumar et. al., 2009). The mechanism for this action is 
unknown in the HKc/SIX1 and HKc/ALL3 cell lines and needs further elucidation. We 
hypothesize that E2F detaches from Rb during the upregulation of SIX1 that leads to cell 
cycle progression and aberrant proliferation of SIX1-expressing cells. E2F can therefore 
activate cell cycle genes, while allowing for the aberrant expression of the embryonic 
gene SIX1.  In turn, Rb mRNA levels rise to increase the production of Rb protein levels. 
However, the rate of Rb protein production cannot be significantly increased in order to 
attach to E2F and inhibit increased cell growth and cell cycle de-regulation (Kumar et. 
al., 2009; Young et. al., 2003). Thus, the misexpression of SIX1 in normal or 
tumorigenic cell lines leads to deregulation of cell-cycle checkpoints, promoting cellular 
proliferation. 
It has been shown that SIX1-expressing malignant cells display larger colony size 
and higher colony formation rate in soft agar while evading anoikis. SIX1 has been 




In concordance with these findings, our experiments of colony formation, including in 
soft agar, demonstrated that HKc/SIX1 and HKc/ALL3 produce robust colony formation 
in monolayer, and survive in suspension, suggesting that SIX1-expressing epithelial cells 
have the increased capacity to replicate and produce a significant number of colonies 
within a shorter period. 
The changes in cellular morphology and behavior, such as growth and invasion, 
which were exhibited in HKc/SIX1 and HKc/ALL3 as a result of SIX1 overexpression, 
lead us to investigate the expression of EMT related genes. Based on our published array 
data from our previous work (Chapter 1), we analyzed the differential expression of 
numerous genes. We validated, through real-time PCR, the increased expression of 
CTGF and decreased expression of ETS1. Tumorigenic cells are known to metastasize 
via blood or lymphatic vessels through an increase in CTGF/CCN2 (Ubink et. al., 2016).
 
Moreover, there was a decrease in the expression of CTNNβ1, in contrast to what we 
observed in our HKc/DR cells that underwent a loss of SIX1. In this present context, this 
could be attributed to a shift away from an epithelial phenotype with changes that follow 
a loss in cell adherens junctions. We also observed a reduction in the expression of the 
epithelial-related genes K15 and OCLN. We noted an increase in the pro-survival factor 
EGFR. Malignant cells are known to escape anoikis through the increase of EGFR 
(Woappi et. al., 2017). Lastly, we noted an increase in ki-67 mRNA level. These data 
suggest that EMT is due to SIX1 overexpression in normal HKc. Therefore, a significant 
increase in these markers parallels an EMT phenotype and is an indication of the 
functional consequences brought on by an increase in SIX1. 
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We have demonstrated that activation of TGF-β pathway is necessary to maintain 
most of the epithelial plasticity from forced SIX1 expression. We have also shown that 
SIX1 is a critical mediator of epithelial plasticity and TβRII induction through its ability 
to induce TGF-β-dependent EMT. We demonstrate that SIX1 expression in HKc/SIX1 
and HKc/ALL3 induces properties of oncogenic EMT. Further, we observed a decrease 
in TβRI and an increase in TβRII in SIX1-expressing epithelial cells. This may indicate 
that an increase in SIX1 expression permits normal HKc to begin their transition away 
from an epithelial and towards a mesenchymal phenotype, as TGF-β switches from a 
growth suppressive to a growth promoter cytokine. 
Stem cells, which are found in normal tissue, have the ability of self-renewal 
through cell division along with the generation of progenitor cells that will eventually 
differentiate into cells and tissues of various functions. Many studies have also 
determined that a small proportion of malignant cells and tissues have self-renewing, 
stem cell like properties (Mani et. al., 2008). These cells have been termed cancer stem 
cells (CSCs). CSCs have the ability to produce new tumors within the heterogeneous 
malignant cell populations (Mani et. al., 2008). Along similar lines, activation of EMT in 
immortalized cells produces many of the properties associated with stem cells, such as 
self-renewal (Mani et. al., 2008). The process of EMT is known to mediate tumor 
progression, metastasis and CSC properties (Christiansen et. al., 2006). Therefore, the 
transient induction of EMT in our HKc/SIX1 and HKc/ALL3 cells may allow for the 
possibility of generating stem cell like features.  
In summary, SIX1 promotes hyperproliferation and invasiveness, indicative of 
cellular transformation, in the background of normal HKc. SIX1 facilitates the 
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establishment of primary human keratinocytes into cell lines with extended life span, or 
perhaps into stem-like cells with extended proliferation potential. The mechanisms 
underlying the pro-tumorigenic and pro-metastatic properties of SIX1 include the 
activation of multiple signaling pathways. We have shown that SIX1 has the ability to 
extend the lifespan of normal epithelial cells and induce an oncogenic EMT pathway 
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